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ABSTRACT 
The actin cytoskeleton is a critical part of intracellular structure, responsible for the general 
shape and integrity of all cells.  New insights into the dynamic nature of the cytoskeleton 
describe additional roles for actin, including synaptic plasticity in the hippocampus, regulation of 
hormone release in endocrine cells, and as a signaling component involved in transcription.  My 
research focused on the hypothesis that changes in actin state contribute to light-induced changes 
in the state of the circadian clock in the mammalian brain.  In early night, the cells of the 
mammalian circadian clock, in the SCN, initiate a series of signaling events to translate 
environmental light into transcriptional changes which induce a delay of clock state.  This 
signaling pathway, mediated by glutamate, involves activation of NMDA receptors, nitric oxide 
synthesis, and opening of ryanodine receptors with subsequent influx of calcium from 
intracellular stores.  Activation of this cascade results in up-regulation of the clock genes, Period 
1 and Period 2.  This induction is mediated in part via CRE elements, through activation of the 
transcription factor, CREB.  Connecting upstream signaling processes with the end result of 
transcriptional changes was a target of this study.   
 Based on responses to glutamate in vitro, I hypothesized that activation of the early night 
light signaling pathway results in a rapid and transient decrease in actin polymerization, which is 
required for the phase delay to occur.  I first characterized actin state around a day-night cycle, in 
order to determine whether sensitivity to actin depolymerization changes over this period.  To 
this end, I showed that polymerized actin peaks in early night, but this oscillation in actin state is 
abolished in mice rendered genetically arrhythmic, the BMAL1 -/- mice.  Secondly, I measured 
actin state after light exposure, and found that brief light pulses induced a breakdown of 
polymerized actin.  By injecting the actin-stabilizing chemical jasplakinolide directly into the 
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mouse SCN, I demonstrated a requirement for actin breakdown in mediating the phase delay, 
while conversely I induced a delay by injecting the actin depolymerzing agent latrunculin A.  
Thirdly, I measured induction of potential downstream effectors upon actin depolymerization, to 
analyze the effect of actin dynamics on transcription.  Breaking down the cytoskeleton with 
latrunculin A resulted in activation of the MAP kinase component PERK, as well as a potential 
activation of PCREB.  The importance of actin dynamics on CRE-mediated transcription was 
demonstrated using electrophysiological recordings, in which inhibition of CRE-mediated 
transcription abolished the effects of latrunculin A on clock state.  Finally, I showed that actin 
depolymerization induced the clock gene Period 2, providing a potential link between 
cytoplasmic signaling events that facilitate actin remodeling and nuclear mechanisms of 
transcription.  This work, together with previous in vitro studies, places actin dynamics firmly 
within the light signaling pathway.  This not only contributes to knowledge about circadian cell 
signaling, but provides a new important role for actin in mediating cellular physiological 
processes. 
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Biological rhythms 
 The daily 24-hour oscillation in light and dark has provided life on Earth with defined 
periods of time to carry out their basic daily functions.  By anticipating these daily cycles, 
organisms gained distinct evolutionary advantages in activities, such feeding, reproduction, or 
rest.  This has resulted in a highly conserved daily biological rhythm in most known higher 
organisms. 
 The first scientific study of daily oscillations was undertaken by Jean Jacques d’Ortous 
de Mairan in 1729. He observed that the daily opening and closing of a heliotrope plant’s leaves 
continued even when the plant was moved to a location receiving no sun.  Many experiments 
followed, providing evidence of an endogenous clock and its “free-running” nature, two essential 
properties of clocks that would eventually become foundations of the circadian field 1. 
 Some of the first modern studies of rhythms in animals were carried out by Colin 
Pittendrigh.  Using Drosophila, he found that flies emerge from their pupa at a specific time of 
day, regardless of environmental temperature, a factor that had been thought to drive rhythms.  
He, together with Serge Daan, then defined many properties of activity rhythms in rodents that 
are still valid and in use today 2-4.  More recently, significant advances in the understanding of 
the genetic structure that underlies circadian rhythms have been made using the Drosophila and 
mouse models, allowing new molecular studies to further knowledge of the inner workings of 
biological clocks 5. 
Mammalian circadian rhythms are generated in the hypothalamic suprachiasmatic nucleus 
 One of the first discoveries into the biology and physiology of biological rhythms was 
elucidating that these rhythms are centrally generated by a specific site in the body.  By 
removing or manipulating organs and systems within rats, Curt Richter found that the central 
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rhythm generator was located in the brain 6.  He then undertook an extensive lesioning study of 
the brain and was able to localize the ventral hypothalamus as the only location in the body that 
resulted in a loss of circadian rhythmicity in rats when removed 7.  This followed a line of 
evidence suggesting that the ventral hypothalamus was involved in regulating sleep 8, 9. 
 In 1972, a series of detailed ablation studies was undertaken that suggested that the 
suprachiasmatic nucleus (SCN) is the hypothalamic area involved in regulating timing.  When 
this region was electrically ablated in rats, oscillations in adrenal corticosterone levels were 
abolished 10.  Additionally, complete ablation of the SCN also abolished rhythms in running-
wheel activity and drinking behavior 11.  In both of these studies, animals that received 
transection of the optic nerve or ablation of only part of the SCN retained these rhythms.  More 
definitive evidence was provided by a study in 1984, in which fetal tissue of SCN-containing 
hypothalamus was transplanted into the third ventricle of an SCN-ablated rat, restoring drinking 
rhythms to that rat 12.  In 1990, fetal SCN tissue from a wild type hamster was transplanted into a 
SCN-ablated hamster with an altered circadian period, restoring rhythms to the wild-type 
phenotype of the SCN donor 13.  These studies led to the conclusion that the hypothalamic SCN 
is the central pacemaker in mammals. 
 The SCN are paired nuclei located directly dorsal to the optic chiasm, and directly lateral 
to the third ventricle (Fig 1.1).  This is an ideal location for a central clock.  The SCN receives 
inputs from many hypothalamic regions, as well as a substantial input from the retina.  Retinal 
inputs provide information to the SCN about environmental light.  Direct retinal projections 
innervate the SCN via the retinohypothalamic tract (RHT).  Indirectly, the SCN receives visual 
input from the retina by projections from secondary visual processing areas, the intergeniculate 
leaflet and pretectal area.  Other regions shown to have direct input to the SCN include the 
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median raphe nucleus, several hypothalamic regions, the basal forebrain, limbic cortex, septal 
area, and brainstem.  The SCN projects to several hypothalamic regions, including the preoptic 
area, subparaventricular zone, dorsomedial hypothalamus, and posterior hypothalamus, as well 
as to regions in the basal forebrain, thalamus, and midbrain 14, 15. 
 SCN neurons are some of the smallest in the brain, and lack the long processes seen in 
other neuronal cell types, such as hippocampal cells 16.  Within the SCN, there are distinct 
regions that participate in different aspects of timekeeping.  The two main divisions define the 
anatomical location of the neurons – the ventral and medial region and the more dorsal and 
lateral region of the nuclei.  The cells of the ventromedial region appear to receive most of the 
visual input as well as input from the dorsal raphe.  This suggests that it is this ventromedial 
region that is responsible for receiving and integrating input signals, which are relayed to the 
laterodorsal SCN area.  The SCN, then, modulates its outputs based on this input from the center 
14, 15.  These divisions are, therefore, both anatomical and functional. 
Endogenous circadian rhythms are generated by neurons in the SCN 
 As originally observed by Curt Richter, circadian rhythms in wheel-running activity 
persist in constant conditions with no time cues.  Endogenous rhythms have even been shown to 
exist when the SCN is isolated from other brain regions.  In 1979, an experiment to isolate the 
SCN neurons from the rest of the brain showed that this “hypothalamic island” maintained a 
rhythm in neuronal activity, while tissue outside of this island did not 17.  Evidence for 
autonomous generation of the rhythm was furthered by three independent studies in 1982, in 
which thin slices of hypothalamus containing the SCN of rats were incubated in a brain slice 
chamber.  When extracellular recordings were made of SCN cells, all three groups found an 
oscillation in the spontaneous firing rate, with a peak in single-unit activity occurring in the 
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donor animal’s subjective day 18-20.  These initial, short-term (< 24 h) studies of oscillatory 
activity were extended to multiple cycles of up to 3 days, demonstrating that the free-running 
period of the SCN in vitro was ~24 h 21.  David Welsh and colleagues furthered these studies 
using patch clamping and multielectrode plates to record multiple cycles of electrical activity 
from dispersed embryonic SCN cells.  They found that individual cells are capable of 
independently maintaining an endogenous rhythm 22.  This implies that the endogenous rhythm is 
generated within the cells of the SCN itself. 
 Specialized techniques have been developed to investigate circadian rhythms in behavior.  
Behavioral activity assays take advantage of a natural tendency for most rodents to run on a 
wheel.  Upon entering the active period of their circadian cycle, rodents immediately begin 
running, and continue to do so, stopping only briefly to eat, drink and groom, until the onset of 
rest.  This behavior of consolidated activity and rest continues even under constant conditions.  
Hamsters, rats, and mice are nocturnal, and so this active period is in the subjective night.  
Because they begin running so precisely at the beginning of the active cycle, this onset in wheel-
running can be used as a marker of phase in constant dark conditions, and is designated as 
Circadian Time (CT) 12.  If the time of onset in activity changes, it indicates a shift in the 
underlying clock mechanism of the animal 23.   
 This behavioral approach is in contrast to that of electrophysiology, which allows the 
study of isolated SCN tissue or even individual cells.  The spontaneously-firing neurons of the 
SCN can be measured using patch-clamp techniques 24, 25, electrodes placed close to cells to 
record single-cell (Green and Gillette 1982) or multi-cell activity 26, or by using large multi-unit 
electrode plates to measure several cells simultaneously 22, 27.  The three studies mentioned above 
from 1982 recorded single units with extracellular electrodes and found that the spontaneous 
 6 
 
firing rate of SCN cells changes around the day-night cycle, and that the peak of firing rate 
occurs in the mid-day.  A shift in this peak time, like a shift on onset of wheel-running, indicates 
a shift in the state of the circadian clock 28. 
A molecular feedback loop drives cellular endogenous rhythms 
 Since these founding studies, the molecular processes that drive endogenous rhythms 
have been elucidated.  The endogenous clock is generated in the cells in mammals by clock 
genes: Clock 29, Bmal1 30-32, two Period genes, Per1 33, 34 and Per2 35-37, and two Cryptochrome 
genes 38, 39.  The clock is driven by a transcriptional-translational feedback loop in which the 
positive elements, BMAL1 and CLOCK, serve as transcription factors for a variety of rhythmic 
genes 40, and also drive the expression of the negative elements, the PERIOD (PER 1/2) and 
CRYPTOCHROME (CRY 1/2) proteins 30, 38, 40.  The PERs and CRYs in turn downregulate the 
positive elements after a delay of many hours because they are sequestered to the cytoplasm due 
to a variety of post-translational modifications, including phosphorylation 41-43, ubiquitination 44, 
45, and sumoylation 46.  Some kinases that are responsible for modifying the clock genes include 
casein kinase 1ε (CK1ε) 42, 47 and glycogen synthase kinase-3β (GSK3β) 48, 49.  Once activated, 
these negative elements dimerize and repress BMAL1 and CLOCK 38, 40.  The entire process 
undergoes an approximately 24-hour cycle, and therefore determines the endogenous, free-
running period in an animal (Fig 1.2).  Because this rhythm is nearly 24 hours, it is termed 
circadian (circa, about; dian, day).   
 An important feature of circadian rhythms is that they are able to coordinate an organism 
to its immediate environment, a process known as entrainment.  This ability to adapt to changing 
conditions involves a phenomenon known as a phase shift.  Any number of environmental 
conditions, such as food availability or certain chemicals, are able to entrain rhythms, but the 
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most important of these entraining zeitgebers (zeit, time; geber, giver) is light.  Environmental 
light information, which is transmitted to the cells of the SCN through the eyes and RHT, is used 
by the clock to synchronize an organism’s rhythm to the time of day, according to the presence 
or absence of light.  This aligns the not-exactly 24-hour endogenous clock with a 24-hour light-
dark (L:D) cycle 50. 
 When referring to the time of day under an entrained condition, such as a 12-h light – 12-
h dark cycle, zeitgeber time is used.  Zeitgeber time (ZT) 0 refers to the start of the day cycle, 
while ZT 12 refers to the start of night.  In contrast, circadian time (CT) is used when referring to 
free-running or endogenous conditions.  CT 0-12 refers to the subjective day while CT 12-0 
refers to subjective night.  The ability of the clock to entrain so readily to a zeitgeber is due to the 
clock’s ability to adjust its phase in response to an inappropriately timed signal.  A phase shift 
occurs when the circadian rhythm changes, and this can occur in either direction.  If a change 
shifts the clock forward in time, it is known as a phase advance, while a change that shifts the 
clock backwards is known as a phase delay.  These alterations can help align an endogenous 
clock during daily or seasonal entrainment, but also allow for larger adjustments of the clock, 
such as those occurring in humans during travel or due to daylight savings time 50. 
The endogenous rhythm can be reset 
 As mentioned above, the clock is sensitive to light and changes its phase as a result of 
exposure to light.  Interestingly, the phase shift that occurs in response to light is different 
depending on the timing of light exposure.  In 1984, a group exposed rats in constant darkness 
(D:D) to light at all different times around a circadian day and then measured the phase shifts in 
the animals’ wheel-running behaviors 51.  The results were expressed as a phase-response curve, 
which plots changes in phase against circadian time, with advances designated as positive 
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changes and delays designated as negative changes in phase.  These data show us that mammals 
respond to light only during subjective night.  The nighttime response is biphasic, in that light 
exposure in the first half of the night causes phase delays in behavior, while light in the second 
half of the night causes phase advances 51, 52.  After this finding, the search was on to identify 
how light information signals to the SCN. 
Glutamate mediates light signaling in the SCN 
 Several neurotransmitters can be measured in the SCN, such as acetylcholine (ACh), 
serotonin, melatonin, GABA, and excitatory amino acids such as glutamate (Glu) and aspartate, 
as well as a variety of neuropeptides, including arginine vasopressin (AVP), vasoactive intestinal 
polypeptide (VIP), neuropeptide Y, and several others 53.  Serotonin and ACh, long known to 
affect SCN rhythms, were not likely to be involved in light signaling, as treatment with serotonin 
or its agonists induces shifts in the clock unlike those seen with light exposure 54-56, while ACh 
depletion or inhibition does not block the light-induced phase changes in wheel-running or the 
evoked field potentials in SCN neurons after electrical stimulation 57-59. 
 Evidence for the excitatory amino acids as mediators of the light response was mixed.  
They had been shown to be released at the SCN after optic nerve stimulation 60, and general 
excitatory amino acid blockage was found to inhibit the electrical response of SCN cells after 
optic nerve stimulation 61.  However, direct injection of Glu into the third ventricle, near the 
SCN, of hamsters did not induce light-like responses in wheel-running behavior, but instead 
induced advances during subjective day and few delays during subjective night 62.  Despite this 
contradictory finding, studies continued to look at Glu and aspartate relating to light responses.  
When MK-801 or 3-(2-Carboxypiperazine-4-yl)-propyl-1-phosphonic acid (CPP), two 
antagonists specific to the excitatory amino acid receptor N-methyl-D-aspartate (NMDA), but 
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not to the other excitatory amino acid receptors, such as kainate and AMPA receptors, were 
injected into hamsters or mice intraperitoneally.  They blocked the light-induced phase shifts in 
wheel-running behavior both in early and late night 63, 64.  Direct NMDA application to an SCN-
containing slice, which activates NMDA receptors in vitro, induced light-like phase shifts in 
electrical activity, whereas blocking NMDA receptors in these slices blocked these NMDA-
induced phase shifts 65.  An anatomical study undertaken during this time found both Glu and 
aspartate immunoreactivity in presynaptic terminals in the SCN, but found much more Glu, 
suggesting that Glu is the excitatory amino acid responsible for these effects 66. 
 Conclusive evidence for Glu mediating the light-induced phase response came from 
studies using Glu, rather than NMDA, to stimulate the light signaling pathway.  Direct 
application of Glu onto in vitro brain slices induced delays in spontaneous peak firing rate in 
early night, advances in this peak in late night, and elicited no effects during the daytime 23, 67.  
When Glu was applied to slices at many points around the circadian cycle, a phase response 
curve in peak firing rate matching that seen for light exposure shifts in wheel-running behavior 
was observed 23, 51.  NMDA antagonists applied with Glu completely blocked these shifts, 
showing that NMDA receptors are required for Glu’s action in shifting the clock 23.  Also in this 
study, they found that application of agents that increase nitric oxide (NO) induce phase shifts 
with the same phase response curve as Glu and NMDA.  This study concluded that Glu is the 
neurotransmitter involved in mediating phase shifts due to light exposure, and also presented a 
possible downstream pathway for this Glu signaling 23.   
 In support of these findings, Watanabe et al. found that application in early night of L-
arginine, a precursor of NO, induced phase delays in firing rate similarly to Glu and NMDA.  
Additionally, blockade of NO synthesis by L-NAME inhibited NMDA-induced delays in the 
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early night, adding support that NMDA acts through NO in the SCN 68.  This was further 
supported in vivo, when L-NAME injection into the third ventricle blocked light-induced delays 
in the early night and advances in the late night in wheel-running activity in hamsters 69.  
 Since these findings, many components of the light signaling pathway have been 
identified.  Cyclic GMP (cGMP), stimulated by NO, also affects the clock in nighttime only.  
cGMP was found to induce advances in neuronal firing rate in SCN slices, but the mechanism 
underlying this was not known at the time 70.  Several studies followed the initial NO findings 
that connected NO synthesis with cGMP and, ultimately, with phase shifting the clock.  This 
pathway, which involves activation of guanylyl cyclase and subsequent production of cGMP, 
thereby activating cGMP-dependent protein kinase (PKG), is only required in late night.  PKG 
inhibitor application blocks the Glu- or light-induced phase advances seen in late night, but has 
no affect on Glu or light effects in early night 71, 72.   
 There is divergence of the signaling pathways activated by light and glutamate in early 
and late night (Fig 1.4).  Light signals in early night require intracellular calcium (Cai2+) 
signaling, as application of thapsigargin, which depletes Cai2+ , inhibits the Glu-induced delay in 
firing rate in SCN slices 71, 73.  This Cai2+ was found to be released from ryanodine receptors 
(RyRs), which are integral membrane proteins found on endoplasmic reticulum that can mediate 
release of Cai2+  74.  Activation of these receptors by caffeine induces Glu-like delays in the early 
night, while inhibition of RyRs by dantrolene or ruthenium red blocks the Glu-induced delay 71.  
 In addition to the primary elements of the light signaling pathway that have been 
described, several other signaling components also play a role.  Because Ca2+ influx results from 
activation of NMDA receptors, the Ca2+/calmodulin-dependent protein kinase (CAMK), cAMP-
dependent protein kinase (PKA), and protein kinase C (PKC) pathways have all been implicated 
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to play important roles.  In support of this, CAMK and PKC are both activated in the SCN after 
exposure to light in the night 75-77.  Levels of the PKA activator, cAMP, are also increased in the 
SCN after light exposure at night 78.  PKA has been shown to have clock-shifting effects in the 
daytime domain, but in the night, application of cAMP has no effect on the clock when applied 
alone.  It is only when cAMP is applied with Glu that the Glu-induced delay is enhanced in 
magnitude.  Additionally, blockage of the cAMP/PKA pathway using the inhibitor KT5720 
results in complete blockage of the Glu-induced delay 78.  This suggests a modulatory role for 
PKA in the early night, but not a role in the primary signaling pathway.  
 CAMKII is another molecule that responds to Ca2+ fluxes and, therefore, has been 
studied in the SCN.   Brief light pulses in the night result in activation of CAMKII 75, 77, while 
inhibition of CAMK in the SCN results in attenuated phase delays after light pulse 77, 79, 80 and 
Glu 81 induction by about 50-60%.  Calmodulin antagonists, which prevent calmodulin from 
activating CAM kinases, also attenuate the Glu-induced delay by the same amount 80.  These 
findings suggest that CAMK plays a role in mediating the phase delay after light, although it is 
not the sole regulator. 
 Similar to CAMKII, PKC activity is rapidly induced in the SCN by light exposure in the 
night.  Interestingly, inhibition of PKC amplifies, rather than blocks, the light-induced delay in 
rhythms.  This inhibition also does not block the rapid induction of the immediate early genes, 
JunB and c-Fos, seen with light exposure, which provides further support that PKC is not part of 
the primary pathway for light signaling, but rather modulates the light response 76. 
 The mitogen-activated protein kinase (MAPK) pathway forms another important 
component of light-induced signaling in the SCN.  Light or Glu treatment in the night induces 
phosphorylation of extracellular-signal regulated kinases (ERKs) 82.  Specific inhibition of 
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MAPK/ERK Kinase (MEK) significantly attenuates light-induced delays in behavior by about 
50%, indicating that MAPK signaling components are important for light signaling 78, 83.  The 
Obrietan group found that MAPK lies downstream of the Glu-induced Ca2+ influx, as inhibition 
of MEK does not inhibit the Ca2+ influx induced by Glu treatment 84.  Additionally, CAMKII lies 
upstream of MAPK signaling, as CAMKII inhibition attenuates the light-induced rise in PERK at 
night 83.   
 ERK activates additional kinases.  Specific downstream kinase targets of ERK activation 
include both the 90-kDa ribosomal S6 kinases (RSKs) and mitogen- and stress-activated protein 
kinases (MSKs), which show increases in activity upon light exposure at night 85, 86, but their 
involvement in downstream events required for phase shifting is still unclear.  This body of 
evidence places the ERK pathway downstream of Glu-induced Ca2+ influx, but further work is 
needed to fully integrate this kinase system into the light signaling pathway. 
Resetting the clock involves transcriptional activation 
 Downstream from activation of the signaling elements described above, light exposure at 
night in the SCN causes transcriptional changes.  cAMP response element-binding protein 
(CREB) is phosphorylated within 5 min of light exposure 87.  Phosphorylated CREB (PCREB) 
induction is mediated by the light and Glu signaling pathway, in that Glu or SNAP, a NO donor, 
application to SCN slices in either early or late night induces PCREB, while NMDA receptor 
inhibitors or NO production inhibitors applied with Glu block this induction 88.  Inhibition of the 
ERK kinase, MEK, blocks PCREB induction, as well 82, 84.  Evidence that CREB mediates 
transcription was acquired using an oligodeoxynucleotide (ODN) containing the CRE 
(Ca2+/cAMP response element) sequence that sequesters CRE-binding proteins to act as a CRE-
decoy 89.  Preincubation of an SCN brain slice with the CRE-decoy inhibits the Glu-induced 
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phase advance.  Additionally, injection of CRE-decoy into the SCN of mice blocks a light-
induced advance in wheel-running activity 90.  The effects of blocking CRE-mediated 
transcription have not been studied in the early night. 
 Light-induced transcriptional changes also include changes in clock gene expression.  
When a light pulse is applied to mice in the early night, mRNA expression for both Per1 and 
Per2 is induced, however Per1 induction is rapid, within 30 min, while Per2 is much slower, 
around 180 min after light pulse 36.  On the other hand, light pulses in late night induce only Per1 
35.  In 2002, a study was undertaken to examine a potential link between PCREB and clock gene 
induction.  This study found that the promoter regions of both Per1 and Per2 contain CRE 
sequences, and that both are able to bind to CREB in vitro.  Additionally, in vitro activation of 
the cAMP or MAPK pathways causes activation of the Per1 promoter, and somewhat smaller 
activation of the Per2 promoter 91.  These results suggest that activation of the light signaling 
pathway in early night induces transcriptional changes via kinases that activate CRE sites, but a 
direct connection between the ryanodine-induced Ca2+ flux and these transcriptional changes has 
not been made.  This gap in knowledge is the subject of my research. 
Actin is a mediator of cellular neuroplasticity 
 In order to identify potential candidates for further signaling components, other CNS 
systems that exhibit changes in state were examined.  The most well studied example of neuronal 
plasticity is that involved in learning and memory formation, found in the cerebral cortex and 
hippocampus.  In the cortex and hippocampus, Glu is the primary excitatory neurotransmitter 
conveying signals to the neurons that undergo long-term state changes.  This Glu activates 
NMDA receptors 92, as well as AMPA receptors 93, inducing a signaling pathway containing 
several elements in common with those of the SCN light signaling pathways, including Ca2+ 
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influxes 94-97, activation of NOS and production of NO 98-101, and activation of kinases (PKA, 
PKG, and the MAPK pathway) 98, 99, 101-105.  In hippocampal neurons, transcriptional changes 
involve regulation by several factors, including PCREB 106, 107.  Many genes are upregulated by 
activation of this signaling pathway, including Arc (activity-regulated cytoskeleton-associated 
gene) 108, 109.  Arc also has been found to be upregulated in the SCN after a light pulse at night 
110.  With these features in common, further consideration of the hippocampal system is 
warranted. 
 The process by which the neurons in the hippocampus undergo long-term state changes is 
known as long-term potentiation (LTP).  This is thought to be an important aspect of memory 
formation.  During LTP, post-synaptic responses are strengthened after stimulation by a 
presynaptic neuron, leading to long-lasting signal transmission 111.  In vitro, this can be initiated 
by tetanic stimulation to an input region of the hippocampus, such as cells of the entorhinal 
cortex, which synapse with granular cells of the dentate gyrus.  LTP also can be initiated by 
NMDA receptor activation 92.  The dendritic spines in these neurons are rich in cytoskeletal actin 
filaments 112-114, and change shape as a result of LTP-induced NMDA and/or AMPA receptor 
activation 93.  LTP and changing actin state were suspected to be linked after it was found that 
blocking actin rearrangements using two chemicals, cytochalasin D (Cyto D) or latrunculin B, 
decreased LTP in hippocampal neurons 115, 116.  Further, stimulation of the entorhinal cortex, 
which initiates LTP in the dentate gyrus molecular layer, caused an increase in F-actin in this 
specific region only, as measured by rhodamine-conjugated phalloidin staining and quantitation 
of F- and G-actin after differential separation by centrifugation and immunoblotting 117.  
Delivering latrunculin A (Lat A), which prevents actin rearrangements, into the dentate gyrus of 
live anesthetized rats inhibited LTP.  This inhibition did not affect the induction phase of LTP, 
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but was only seen in later stages 117.  These findings also have been supported in vivo.  When Lat 
A or Cyto D were injected after fear conditioning into dorsal hippocampus or the amygdala of 
mice or rats, the freezing response, which demonstrates memory of the fear conditioning, was 
diminished 118, 119.  These findings imply that actin changes are necessary for long-term 
maintenance of learning.  Impairment after injecting actin-stabilizing chemicals into the 
amygdala demonstrates that not just the hippocampus but other regions involved in learning and 
memory consolidation require actin remodeling. 
 Similarities of the light signaling pathway in the SCN to that of the learning and memory 
system suggest a potential involvement of actin rearrangements in Glu-induced state changes in 
the SCN.  Actin is a ubiquitous molecule found in all eukaryotic cells.  It exists in two forms:  
monomeric actin (globular or G-actin) molecules and polymeric actin (filamentous or F-actin) 
molecules (Fig 1.5).  In living cells, there is a dynamic shift between the two forms, with 
constant turnover of G-actin from the F-actin strands.  New actin monomers are added to one end 
of the strand, termed the “barbed” end, while monomers or small oligomers are removed from 
the opposite end of the strand, termed the “pointed end” 120.  These actin strands form the 
microfilament component of the cytoskeleton and play roles in many cellular processes.  
Cytoskeletal functions include cell support and structure, as well as providing a scaffold for 
intracellular and membranous cell components to bind 121.  Another important role for actin is 
cell migration, such as that seen in macrophages and during development 122.  
 More recently, actin has been suggested to be involved in signaling.  In a 2002 study, 
actin was found bound to the transcription factor Nrf2 in rat hepatoma cells, until a specific 
stimulus, oxidative stress, resulted in F-actin depolymerization and release of this bound 
transcription factor.  As a result of being released from actin filaments, Nrf2 translocates to the 
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nucleus and regulates expression of genes initiating a stress response 123.  The same group then 
found that actin-Nrf2 interactions are mediated through Keap1, an actin-binding protein which 
senses oxidative stress and releases bound Nrf2, thereby allowing Nrf2 to translocate to the 
nucleus 124.  This indicates that the actin cytoskeleton may be involved not only in structural 
changes, but in internal cellular signaling, as well. 
 Another role for actin has been demonstrated in the vasopressin (AVP) and oxytocin 
secreting cells of the supraoptic nucleus (SON) of the hypothalamus, as well as in insulin-
secreting β-cells of the pancreas.  In both types of endocrine cells, secretion of peptide hormone 
seems to require rapid and transient actin depolymerization 125, 126.  Stabilization of actin 
filaments using the chemical jasplakinolide (Jasp) prevents oxytocin or AVP release in SON 
cells 125, while application of actin depolymerizing agents, such as Lat A and Cyto B 125-128, 
results in release of peptide stores.  For these and other secretory cells, such as catecholamine-
secreting chromaffin cells, rapid breakdown of the cortical actin, which forms a meshwork under 
the plasma membrane, is thought to allow for hormone-filled vesicles to fuse to the membrane 
and release their contents 125, 128, 129.  Elucidating the mechanisms for this actin-induced vesicle 
release continues. 
 Preliminary findings from our lab support a role for actin in signaling.  When Glu is 
applied to SCN slices in vitro, an approximately 25% decrease in the F-actin:G-actin ratio 
occurs, indicating a depolymerization.  Additionally, when SCN slices are incubated with the 
actin-stabilizing chemical, jasplakinolide, Glu-induced delays in firing rhythms are inhibited, 
whereas chemicals that induce a decrease in F-actin, Cyto D or Lat A, induce a delay directly, 
without Glu stimulation 130.  These findings provide the first evidence that actin changes in the 
SCN may be a required component of the long-term state changes that are phase delays. 
 17 
 
Statement of problem and hypothesis 
 The preliminary results presented above have allowed me to hypothesize that actin 
rearrangements are a necessary component of the light signaling pathway in the SCN in the early 
night.  In order to test this hypothesis, I have undertaken the following specific aims: 1) Examine 
the actin state in the SCN at various points in the day-night cycle, in order to determine if there 
are differences in sensitivity to changes in actin state.  2) Examine actin state in response to light 
exposure in early night, and determine whether changes are required for a phase delay to occur.  
3) Evaluate how actin changes mediate transcriptional changes by examining PCREB and clock 
gene induction.  The outcome of this study characterizes actin’s role in the response to light, 
defining more clearly the early night light signaling pathway, and also extending the potential 
role for actin in signal transduction and transcriptional activation. 
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Figures 
 
 
 
 
 
 
 
 
Fig. 1.1 The suprachiasmatic nucleus is in the ventral hypothalamus of mammals.  A. 10x 
DAPI-stained image of mouse SCN.  B. 4x cresyl-violet stained image of mouse SCN.  Scale bar 
= 200 µm. 
 
 
  
 19 
 
 
 
 
 
 
 
Fig. 1.2 A transcriptional-translational feedback loop drives cellular rhythms.  The positive 
clock elements, CLOCK and BMAL1 (Brain and Muscle Arnt-like protein 1), drive transcription 
of the negative elements, the Period (Per) and Cryptochrome (Cry) genes.  These are translated 
and feed back to inhibit CLOCK and BMAL1.  Phosphorylation by kinases, such as casein 
kinase 1ε (CK1ε), is one component controlling PERIOD and CRYPTOCHROME subcellular 
location.  Redrawn from Gallego and Virshup 2007. 
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Fig. 1.3 The effect of light on circadian rhythms is time-of-day specific.  In animals in 
constant conditions, including constant darkness, the circadian clock continues to keep near-24-h 
time, circadian time.  During subjective day, exposure to light induces no change in phase of the 
clock.  During early subjective night, light induces a delay in the clock, while in late subjective 
night, light induces an advance in the clock.  Redrawn from Summer et al. 1984. 
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Fig 1.4 Early night light signaling pathway in the SCN.  NMDA receptor activation by Glu 
induces a series of steps required for phase delay in the early night.  RHT = retinohypothalamic 
tract, Glu = glutamate, NMDA-R = N-methyl-D-aspartate receptor, Ca2+ = calcium (i denotes 
intracellular), NOS = nitric oxide synthase, NO = nitric oxide, Ry-R = ryanodine receptor, 
CAMK = Ca2+/calmodulin-dependent protein kinase. PKC = protein kinase C, PKA = cAMP-
dependent protein kinase, MEK = MAPK/ERK kinase, ERK1/2 = extracellular-signal regulated 
kinases 1 & 2, PCREB = phosphorylated cAMP response-element binding protein, Per1/2 = 
Period 1 and Period 2.  Redrawn from Gillette and Mitchell 2002. 
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Fig. 1.5 The actin cytoskeleton is a dynamic structure that exists in two states. Addition of 
monomeric G-actin molecules to the barbed end of a growing F-actin filament is in dynamic 
equilibrium with removal of G-actin from the opposite pole, the pointed end, of F-actin.  This 
process is ATP-dependent.  (Korn et al. 1987) 
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CHAPTER TWO 
THE STATE OF THE ACTIN CYTOSKELETON OF THE SCN AROUND THE CLOCK 
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Abstract 
The actin cytoskeleton plays a critical role in diverse cellular functions, including cell migration, 
scaffolding, formation of new memories, and even signaling.  The dynamic nature of actin is 
highly regulated by a variety of signaling components, which act on actin-binding proteins to 
modify actin filaments for specific functions in the cell.  Many of these regulatory signaling 
molecules also have been shown to play a role in light signaling to the central circadian clock.  
Many of these signaling components oscillate in a circadian fashion, resulting in specific 
temporal windows of sensitivity for these molecules to act on the cells of the clock.  In this study 
I examined actin polymerization state around the day-night cycle in order to determine if actin 
state also displays specific windows of sensitivity to change.  Additionally, I examined actin 
state in an arrhythmic mouse model lacking a functional molecular clock, in order to assess 
whether oscillations in actin state are endogenously driven by the circadian clock.  I found that 
F-actin levels in the SCN oscillate, peaking in early night.  This oscillation is abolished in 
arrhythmic mice.  These findings support the notion that the circadian clock regulates actin 
dynamics, and support a potential role for actin in signaling within these cells.   
 
Introduction 
 Actin is a ubiquitous protein that plays a role in a wide variety of cellular processes.  
While originally identified in its role in contractile muscle tissue, actin forms the main structural 
component of microfilaments, which serve as a critical scaffold and flexible support structure 
present in all eukaryotic cells.  Actin protein monomers, termed “globular (G-) actin”, assemble 
into long strands, termed “filamentous (F-) actin,” which are the functional form of the protein.  
This assembly is ATP-dependent and occurs faster on one end of the growing filament, termed 
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the “barbed” end.  Assembly on the barbed end and disassembly on the opposite pole of the 
filament, the “pointed” end, lead to a dynamic turnover of the filament 131. 
 Many types of actin-binding proteins are known to play roles in regulating 
assembly/disassembly of actin.  The Rho GTPase family, which includes Rho, Rac, and Cdc42, 
receive and transmit signals from cell surface receptors to cytoskeletal effectors which then 
affect actin state 132.  G-actin binding proteins include profilin, ADF/cofilin, and thymosin-β4, 
among others.  These proteins bind and sequester G-actin, and therefore regulate availability of 
monomers for filament assembly and disassembly 131.  The Arp2/3 complex, along with a group 
of proteins known as nucleation-promoting factors (NPFs), are responsible for the nucleation of 
the first actin monomers, which will ultimately form a new F-actin strand 133, 134.  Members of 
the Ena/VASP family of proteins play a role in strand elongation in several important cellular 
functions, including cancer cell migration 131, 133, while formins regulate assembly of F-actin 
networks that are unbranched, such as those seen in filopodia 135.  The spectrin family of proteins 
mediates crosslinking of filaments to other F-actin polymers, and also to organelles and the 
plasma membrane 136.  These few examples of actin-binding proteins illustrate the variety of 
factors that regulate the dynamic assembly and disassembly of actin filaments. 
 Actin polymerization state can be changed as part of several important physiological 
functions.  Actin rearrangements are crucial to migratory cell movement, such as that seen in 
neutrophils or invasive cancer cells 122.  In order to move, chemoattractant chemicals bind to cell 
membrane receptors, which signal effector molecules in the cell, often the Rho-GTPase family.  
Actin polymerization at the leading edge of the cell and depolymerization at the back of the cell, 
together with the formation of new adhesions at the front of the cell and breaking of adhesions at 
the back of the cell, contribute to the cell moving in the direction of the chemical signal 122, 137.   
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In the brain, actin-rich dendritic spines on neurons of the hippocampus and cortex change shape 
as a result of stimulation during long-term potentiation, and it is the rearrangement of the actin 
filaments that is responsible 115, 116.  A further function for actin is in signaling.  In rat hepatoma 
cells, oxidative stress can induce cytoskeletal breakdown.  This allows the transcription factor 
Nrf2 to be released from actin and translocated to the nucleus, where it upregulates expression of 
genes involved in the oxidative stress response 123.   
 In all of these systems, actin changes are regulated through various cell signaling 
components.  Calcium (Ca2+) fluxes are a common consequence of signaling pathway activation, 
and often lead to changes in the cytoskeleton 121, 138.  For example, the Ca2+-sensitive calmodulin 
kinase (CAMK) II is one signaling molecule that is associated with rearrangment of the 
cytoskeleton 139, 140.  This kinase is involved in a variety of cellular responses to a stimulus, 
including long-term potentiation in hippocampal cells 141-143 and oxidative stress response in 
vascular cells 144, 145.  Additionally, actin changes are often associated with activation of MAP 
kinase signaling components, as in the hippocampus, where actin rearrangements and the ERK 
pathway are important for long-term potentiation 104, 115, 116 and memory formation 118, 119, 146. 
 Preliminary evidence from our lab and new findings presented in chapter 3 of this 
proposal indicate a role for actin in circadian plasticity.  In the early subjective night, light 
induces a series of signaling events in the cells of the central circadian clock, the suprachiasmatic 
nucleus (SCN), resulting in a delay of clock state.  Transient actin depolymerization has been 
found to be a necessary component of this signaling pathway, which include extracellular Ca2+ 
influxes and activation of CAMKII 75, 77, production of nitric oxide with subsequent activation of 
ryanodine receptors 71, and activation of the MAP kinase ERK pathway 82-84.   
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 Many of these signaling components have been found to oscillate in a circadian fashion.  
For example, the phosphorylated form of ERK, PERK, peaks in the middle of the day, around 
circadian time 8 (CT 8, 8 hours from the beginning of subjective day) 82, 147, 148, while the 
phosphorylated, active form of CAMKII peaks around CT 4 75.  In addition to these components, 
a wide variety of other clock components required for a delay in the clock also oscillate, 
including PCREB, which peaks in late night (CT 18-22) 149, and transcription of the clock genes 
Period 1 and Period 2, with peak mRNA occurring in the second half of the day 33-36.   
 In this study, I evaluated actin polymerization state in the SCN around the day-night 
cycle in order to determine whether this state oscillates in a circadian fashion.  Preliminary 
evidence from our lab using a centrifugation-based F- and G-actin separation indicates a 
circadian oscillation in rat SCN with peak actin polymerization occurring over the day-night 
transition, from CT 10-14.  I found that F-actin state in mouse SCN oscillates as well, with a 
peak in the early night.  Additionally, I utilized a transgenic mouse that lacks a functional central 
clock in order to examine whether the oscillation in actin state is clock-driven, and found that 
actin state oscillations are abolished in these mice.  These findings about the oscillating state of 
actin in the SCN provide clues to its role in clock signaling, which will be explored in further 
chapters of this dissertation. 
 
Materials and Methods 
Animals and circadian time 
 Male C57Bl/6 mice 6-12 weeks of age, obtained from Jackson Laboratories (Bar Harbor, 
ME) were used for this study.  Mice heterozygous for the clock gene BMAL1 (BMAL1 +/-) 
were obtained from Jackson Laboratories and bred to produce BMAL1 -/- mice.  This genotype 
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was determined by PCR (Fig. 2.1 A).  BMAL1 -/- mice lack circadian rhythms under constant 
conditions (Fig. 2.1 B) 150.  The BMAL1 -/- mice were placed in total darkness (D:D) for three 
days, and tissue collection occurred at the same circadian timepoints as the wild type controls 
and labeled as “approximately circadian time __”, as previously described 150.  Rodents were 
housed under standard conditions in 12-h light:12-h dark (L:D) cycles or constant darkness 
(D:D) and given food and water ad libitum.  All animals were maintained and cared for in full 
compliance with NIH guidelines for the humane treatment and care of animals under protocols 
approved by IACUC of the University of Illinois.   
Tissue collection and brain slicing  
 Mice were sacrificed in the day, and reduced slices placed into a brain slice chamber.  
Slices were perfused continuously with Earle’s balanced salt solution (EBSS) supplemented with 
24.6 mM glucose, 26.2 mM sodium bicarbonate and 5 mg/L gentamicin and saturated with 95% 
O2 / 5% CO2.    At the appropriate CT (CT 2, 6, 10, 14, 18, or 22), tissue was collected from the 
chamber and frozen on dry ice.  Tissue from three mice was pooled for each time point.  For 
phalloidin and DNase histochemistry, mice were transcardially perfused with 50 ml cold 0.9% 
saline, followed by 50 ml 4% paraformaldehyde, at the appropriate time of day (ZT 2, 6, 10, 14, 
18, or 22).  
Phalloidin and DNase staining 
 Whole brains from perfused mice were post-fixed in 4% paraformaldehyde overnight and 
then sliced into 40-µm sections using a vibratome.  These were collected into Watson’s 
cryoprotectant for storage at -20°C.  Upon thorough rinsing to remove cryoprotectant, sections 
were blocked in bovine serum albumin (BSA, Sigma, St. Louis, MO) for 90 min and then 
incubated with rhodamine-phalloidin and Alexa-fluor 488-DNase (phalloidin: 2 units/mL, 
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DNase: 10 µg/mL, in 1% BSA/0.03% Triton X-100-PBS; Invitrogen, Carlsbad, CA) for 2 h at 
room temperature.  Slices were then incubated with DAPI (0.2 µM, Invitrogen) for 5 min at 
room temperature.  Slices were mounted to gel-coated glass slides and coverslipped using 
Prolong Gold Anti-Fade solution (Invitrogen).  Staining was evaluated using a Zeiss Meta 510 
LSM confocal microscope or a Nikon fluorescent microscope. 
 F-:G-actin separation assay and western blotting 
 For each sample, SCN-containing reduced slices from 3 mice were pooled.  One hundred 
µl of cell lysis buffer (20 mM HEPES pH 7.2, 100 mM NaCl, 1 mM sodium orthovanadate, 1% 
Triton X-100) containing protease inhibitor (Complete Protease Inhibitor Cocktail, Roche, 
Indianapolis, IN) was added to each sample and then samples were lysed by trituration.  Thirty-
five µl of this whole cell lysate was collected, spun briefly to remove membrane debris, and the 
supernatant saved as the “total actin” sample.  The remaining cell lysate was centrifuged at 
10,000 x g for 20 min.  The supernatant containing G-actin was collected.  The pellet, containing 
F-actin, was then redissolved in RIPA buffer (50 mM Tris pH 8, 150 mM NaCl, 0.1% SDS, 1% 
NP40, 0.5% sodium deoxycholate) containing protease inhibitor (Complete Protease Inhibitor 
Cocktail, Roche) for 1 h, and then centrifuged again at 12,000 x g for 30 min.  This supernatant 
was collected as the F-actin fraction and the pellet was discarded.  Total protein content from 
each sample was determined using the Micro BCA Protein Assay (ThermoFisher Scientific, 
Waltham, MA). 
 Separated samples were resolved by western blotting.  Twenty-five µg of total protein 
from each sample was mixed with Laemmli buffer and denatured at 95°C for 5 min.  Samples 
were then separated by 8% SDS-PAGE and transferred to nitrocellulose (Biorad, Hercules, CA).  
Following blocking in 5% milk, membranes were probed with anti-β-actin polyclonal antibody 
 30 
 
(Sigma) overnight at 4°C.  As a loading control, blots were probed with anti-α-tubulin (Sigma).  
Membranes were developed using Supersignal chemiluminescent substrate (Thermofisher 
Scientific) and visualized using a Biochemi Imaging System (UVP, Upland, CA).  Levels of 
total, G-, and F-actin were determined using densitometry and compared to tubulin as a loading 
control. 
 
Results 
Actin polymerization state oscillates in the SCN around the circadian cycle 
 To examine the endogenous state of the actin cytoskeleton across the day-night cycle, 
tissue from mice was collected at various points around the day and night and actin state was 
evaluated using two methods: 1) F- and G-actin separation and 2) phalloidin and DNase 
histochemistry.  Differential centrifugation of SCN tissue lysate followed by western blot 
analysis allows for the ratio of F-actin:G-actin to be measured.  Using this technique in wild-type 
C57 mice, the ratio of F-:G-actin peaks in early night, at CT 14 (Fig. 2.2).  At this time of night, 
F-:G-actin is >25% higher than at all other time points examined (p < 0.05, Student’s t-test (CT 6 
vs CT 14), p < 0.001, Student’s t-test (CT 10 vs. CT 14), n = 4).  
 Phalloidin, which binds specifically to F-actin 151, 152, and DNase, which binds 
specifically to G-actin 153, 154, can be used to evaluate actin state.  By measuring the level of each, 
a ratio of phalloidin:DNase can also be used to determine F-:G-actin 153.  Staining the tissue of 
mice collected around the day and night with these two compounds also yielded a significant 
oscillation in actin state, as a peak in the F/G-actin ratio is demonstrated at ZT 14.  However, an 
additional peak at ZT 2 is observed (Fig. 2.3, p < 0.01, 1-way ANOVA, n = 4).  
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Actin polymerization is dependent on a functional molecular clock 
 In order to evaluate whether the changes in actin state in the SCN are driven by an 
oscillating molecular clock, F- and G-actin state was measured by phalloidin and DNase staining 
in tissue from mice that lack the gene encoding a core molecular clock protein, BMAL1.  These 
BMAL1 - /- mice are arrhythmic under constant conditions.  F-:G-actin ratios measured from 
these mice do not show any significant changes around the circadian day (Fig. 2.4, p = 0.9313, 1-
way ANOVA, n = 3), suggesting that a functional clock must be present to drive the oscillation 
in actin polymerization state. 
 
Discussion 
 The findings presented above demonstrate an oscillation in F-actin state in the cells of the 
SCN in mice across the day-night cycle.  This oscillation is similar to that seen in rat tissue 
(Kandalepas and Gillette, unpublished), which was evaluated using F- and G-actin separation 
and western-based techniques.  In rats, the F-:G-actin ratio peaked between CT 10 and CT 14, 
whereas in mice I report a clear peak at CT 14, using the same technique in mice to measure 
actin state.  This slight difference between the two rodent species is not unexpected, as the 
endogenous period of mice is shorter than in rats, and consequently the phase response curve is 
not identical 23, 155. 
 This study also utilized a second method to measure actin state, phalloidin and DNase 
histochemistry.  Rhodamine-conjugated phalloidin is commonly used in laboratories to visualize 
cell shape.  In this study, however, the presence of actin in every cell resulted in difficulties 
measuring overall changes in staining in a specific brain region.  As such, the differences 
measured between various times of day are much smaller, though significant.  Additionally, 
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because the F- and G-actin separation technique requires tissue from 3 mice to be pooled while 
staining does not, individual differences between animals may result in small differences and a 
higher error in staining from one set of mice to another.  Conversely, the phalloidin and DNase 
staining technique allows for a more specific documentation of actin remodeling in the SCN 
only, whereas the western-based F- and G-actin separation will always contain some non-SCN 
hypothalamic tissue in the reduced slices.  These differences in technique may also account for 
inconsistencies between the two. 
 Regardless of these potential discrepancies, both techniques suggest an oscillation of 
actin state in the SCN which peaks in the early night in mice.  In the early night, the SCN is 
sensitive to light from the visual system, acting through a glutamate-based signaling pathway to 
produce a delay of clock state.  As preliminary findings from our lab and data in chapter 3 show, 
actin depolymerizes as part of this signaling pathway.  F-actin content is high at this time of the 
night, which may result in the more robust depolymerization that is seen compared to mid-day 
(Tyan and Gillette, unpublished observations). 
 Oscillation of cytoskeletal elements is not restricted to the SCN.  A recent study 
measured both actin and tubulin polymerization state in the hippocampus of rats, and found that 
actin state changed in this brain region in light vs. dark conditions, while tubulin state did not 
oscillate significantly 156.  In the hippocampus, this actin oscillation was shown to be regulated 
by melatonin, which is secreted in the absence of light 157, because pinealectomy abolished this 
effect 156. 
 The oscillation of actin state measured in the SCN of wild-type mice was abolished in 
BMAL1 -/- mice.  These mice are able to entrain to light-dark cycles, but once placed in constant 
conditions, such as total darkness (D:D), they become arrhythmic rapidly 150.  They have been 
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used to evaluate the effect of molecular arrythmicity on various aspects of physiology, including 
effects on metabolism and insulin secretion 158-161, the cardiovascular system 162-166, oscillations 
in the oxidation and reduction state of the SCN 167, along with several others 168-175.  In this 
study, staining with phalloidin and DNase yielded measurable F-:G-actin ratios, but they did not 
vary significantly across the day-night cycle.  This suggests that the oscillation of the core clock 
protein BMAL1 is involved in the regulation of actin polymerization state.  It remains to be seen 
whether the abolished oscillation in actin state is specific to BMAL null mice.  BMAL1 has been 
shown to be an important regulator of skeletal muscle tissue, as BMAL1 -/- mice show 
abnormalities in microfilament organization in muscle cells 169.  Therefore, examining actin state 
in other models of arrythmicity, such as long-term exposure to total light (L:L) or the double 
knockout of two period genes, the Per1 -/- / Per2 -/- mouse, may provide further details about 
the regulation of actin by the clock. 
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Figures 
 
 
Fig. 2.1 BMAL1 -/- mice display arrythmicity in constant conditions.  A. DNA gel 
electrophoresis is used to identify the genotype of BMAL1 -/- mice.  The wild-type BMAL1 
band runs at 399 bp, and the mutant band runs at 600 bp.  Mice displaying only the mutant band 
are used for experiments.  B. Actograms showing running-wheel behavior for a wild-type (top) 
and BMAL1 -/- (bottom) mouse.  In L:D conditions, both show entrainment, but when placed 
into constant D:D conditions, the BMAL1 -/- rapidly becomes arrhythmic.  Image from Bunger 
et al. 2000. 
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Fig. 2.2 Actin polymerization state oscillates around the day-night cycle.  A.  F- and G- actin 
fractions separated by centrifugation and quantified by western blotting technique are normalized 
to total, unseparated actin levels.  B. F/G-actin ratio peaks in the early night, around CT 14.  C. 
Total actin levels do not show a peak of actin at CT 14.  n = 4, * p < 0.05, *** p <  0.001, 1-way 
ANOVA with Tukey’s post-test. 
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Fig. 2.3 Actin polymerization state measured by staining oscillates around the day-night 
cycle.  Rhodamine-phalloidin (red), and Alexa-fluor 488-DNase (green) staining of wild-type 
mouse SCN tissue collected around the day-night cycle shows a peak in F-:G-actin at ZT 2 and 
ZT 14.  DAPI staining (blue) was used to define the borders of the SCN.  n = 4, p < 0.01, 1-way 
ANOVA with Tukey post-test, scale bar = 100 um.   
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Fig. 2.4 Actin polymerization state measured by staining in arrhythmic mice does not 
oscillate around the day-night cycle.  Rhodamine-phalloidin (red), and Alexa-fluor 488-DNase 
(green) staining of BMAL1 -/- mouse SCN tissue collected around the day-night cycle does not 
show any significant differences in F-:G-actin.  DAPI staining (blue) was used to define the 
borders of the SCN.  n = 3, p = 0.9313, 1-way ANOVA, scale bar = 100 um. 
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Abstract 
Activation by light of a glutamate-mediated signaling pathway results in a delay of the circadian 
clock in the early subjective night.  While many components of this pathway are known, 
including a requirement for calcium (Ca2+) influxes, nitric oxide production, and activation of 
ryanodine receptors and subsequent Ca2+ release from internal stores, downstream components 
are less clear.  The findings presented here support the hypothesis that the actin cytoskeleton is a 
required component of this light signaling pathway.  Brief light pulses in the early night induce 
transient decreases of polymeric actin.  Additionally, exogenous application of actin-disrupting 
chemicals induce light-like phase delays, while blocking actin depolymerization blocks light-
induced delays of the clock.  These findings provide evidence for the necessity of actin 
rearrangement in the SCN during light-induced signaling. 
 
Introduction 
 Aligning an organism to its ambient environmental condition is essential for carrying out 
appropriate daily physiological processes.  The central circadian clock in mammals plays a 
critical role in maintaining this homeostasis, and is located in mammals in the homeostatic center 
of the brain, the hypothalamus, in the suprachiasmatic nucleus (SCN) 14, 15.  To maintain this 
homeostasis, the clock receives time cues from its surroundings and adjusts itself accordingly, 
sending timing information to various tissues.   
 One important time cue is environmental light.  The SCN receives light through a 
retinohypothalamic projection.  Light exposure during an organism’s subjective night signals that 
it is out of phase with its environment. The result is a shift in timing of the circadian clock to 
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realign it with the environment.  In the early subjective night, light exposure signals that sunset is 
later than anticipated, and results in a delay of the clock 51. 
 A series of signaling events occur in the cells of the SCN that facilitate this change of 
clock phase.  Light signals from the eye are transmitted through the retinohypothalamic tracts 
(RHT) to the SCN, releasing the excitatory neurotransmitter glutamate (Glu) onto the cells 60.  
This Glu activates a variety of receptors, including the NMDA receptor, and the resultant Ca2+ 
influx is responsible for further downstream events 23, 65, 67.  Nitric oxide synthase is activated by 
this Ca2+ influx 23, 68, 69.  In the early night, the nitric oxide produced results in activation of 
ryanodine receptors on internal cell membranes, which, when activated, release Ca2+ from 
internal stores into the cytoplasm 71.  The processes occurring downstream of this second wave 
of Ca2+ influx are the subject of the current study.   
 Intracellular Ca2+ changes have been associated with a wide variety of cell signaling 
events 138.  A common effect of increasing cytosolic Ca2+ in neurons is cytoskeletal 
reorganization 121.  In the hippocampus, neurons receive input signals through Glu acting through 
NMDA and AMPA receptors on dendritic spines 92, 93, which results in a local increase in Ca2+ 94-
96.  One effect of this Ca2+ increase is rearrangement of actin, allowing the dendritic spines to 
change to a shape most effective for new memory formation 93, 176, a primary function of the 
hippocampus.  In fact, actin rearrangements have been found to be required for memory 
formation.  In vitro, chemicals that prevent actin from polymerizing, latrunculin B (Lat B) and 
cytochalasin D (Cyto D), were incubated with hippocampal brain slices before electrical or 
chemical stimulation.  This pre-incubation was able to block long-term potentiation from 
occurring, thereby preventing the electrical state that the hippocampal cells must achieve for 
learning to take place 115, 116. Actin changes have also been shown to be required in vivo, as the 
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same actin-stabilizing chemicals injected into the amygdala of mice or rats before fear 
conditioning block the learned response of freezing after a sound pulse 118, 119.   
 Preliminary findings suggest actin dynamics are also involved in light signaling in the 
SCN.  Stimulation of the light signaling pathway by Glu in SCN brain slices results in a transient 
decrease in polymerized, or F-actin, although total actin levels do not change.  This decrease in 
F-actin seems to be required for a delay in the clock, as stabilization of actin by the chemical 
jasplakinolide (Jasp) before application of Glu blocks the Glu-induced delay in vitro.  
Conversely, breaking down F-actin using the chemicals Lat A or Cyto D is sufficient to induce a 
delay in the clock similar to that seen with Glu application 130. 
 The importance of actin dynamics in the hippocampus and the preliminary findings 
presented above led me to examine actin state as a result of light in the early night in the SCN.  
Using a centrifugation and western blot-based assay, I found that a brief light pulse can induce a 
decrease in F-actin in SCN tissue.  This was verified by a second method using histochemistry to 
measure actin state with phalloidin and DNase staining.  Additionally,  actin state changes can 
adjust the clock.  I found that a delay can be induced in onset of wheel-running behavior through 
exposure to the actin depolymerizer, Lat A.  Conversely, stabilizing F-actin by injection of the 
compound Jasp can attenuate light-induced delays in early night, thereby demonstrating the 
necessity of actin depolymerization in the SCN after exposure to light. 
 
Materials and Methods 
Animals and circadian time 
 Male C57Bl/6 mice 6-12 weeks of age, obtained from Jackson Laboratories (Bar Harbor, 
ME) were used for this study.  These rodents were housed under standard conditions in 12-h 
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light:12-h dark (L:D) cycles or constant darkness (D:D) and given food and water ad libitum.  
All animals were housed and cared for in full compliance with NIH guidelines for the humane 
treatment and care of animals and animal protocols have been approved by IACUC at the 
University of Illinois.   
 In order to determine circadian time for animals living in constant conditions, mice were 
housed singly in cages equipped with a running wheel.  Running-wheel activity was measured by 
rotation of the wheel.  This rotation causes a magnet on the wheel to pass a hermetically-sealed 
switch, which completes a circuit.  This information was processed on a computer containing 
LabView software and then plotted into actogram form using Clocklab Analysis running in 
Matlab (Actimetric Inc., Wilmette, IL).  Onset of activity, which by convention occurs at 
circadian time (CT) 12, was used to determine the treatment time for each individual mouse. 
Intra-SCN cannulation surgeries 
 Surgeries were performed at approximately 6 weeks of age (18-22 g).  At least 1 h prior 
to the procedure, mice received buprenorphine (0.03 mg/kg i.p.) or carprofen (5 mg/kg i.p.) as an 
analgesic.  Under deep anesthesia (60 mg/kg sodium pentobarbital i.p. or 1-2% isofluorane), 
mice were secured into a stereotaxic device in order to minimize movement and for correct 
placement of the cannula.  After exposing the skull, a small machine screw (0-80 x 1/16, Plastics 
One, Roanoke, VA) was drilled into the skull to help secure the cannula.  Either a guide cannula 
(26 ga, 11.2 mm total length, Plastics One) or a microdialysis guide (CMA7, CMA 
Microdialysis, Chelmsford, MA) was aligned with bregma and then adjusted to coordinates 
experimentally determined to correspond to the SCN in mice (guide cannula: anterior-posterior -
0.1 mm, medial-lateral -0.1 mm, dorsal-ventral -2.0 mm; microdialysis guide: anterior-posterior -
0.1 mm, medial-lateral -0.1 mm, dorsal-ventral -3.4 mm).  A small hole was then drilled into the 
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skull at this location, and the cannula was inserted into the brain.  For microdialysis guides, a 
small peg was glued to the skull to be used for tethering (Harvard Apparatus, Holliston, MA).  
Superglue and cranioplastic cement were used to secure the entire apparatus.  A 33-ga stylet was 
placed into the cannula to maintain its patency.  Mice received buprenorphine (0.05 mg/kg i.p.) 
or carprofen (5 mg/kg i.p.) as a post-operative analgesic 12-24 h following surgery and 
additionally as needed.  Mice were then allowed to fully recover for at least 10 days before 
undergoing any further treatments. 
Wheel-running activity monitoring 
 Upon recovery, mice were individually housed in a cage containing a running wheel, 
with two cages residing in a circadian activity monitoring system (CAMS).  These are light-tight, 
ventilated, and the lighting is specifically controlled for each CAMS by computer.  After 
adjusting to the wheel, mice were placed into these CAMS in constant darkness (D:D).  Running 
wheel activity was measured by rotation of the wheel.  This rotation causes a magnet on the 
wheel to pass a hermetically-sealed switch, which completes a circuit.  Onset of activity, which 
by convention is designated as CT 12, was used to evaluate changes in the clock state.  This 
information was sent to a computer with LabView software.  The information was then plotted 
into an actogram using Clocklab Analysis running in Matlab (Actimetric Inc.).  The magnitude 
of phase shift was determined by measuring the distance between the computer-generated 
regression lines plotted against onset of activity before and after treatments.    
Behavioral treatments 
 After mice recovered fully and wheel-running activity was established, mice were 
removed from their cages at the appropriate CT in dim red light (<1 lux).  For acute injections, 
mice were gently restrained and a 10-μl Hamilton syringe fitted with a 33-ga infusion cannula 
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extending 3.4 mm below the guide cannula (Plastics One) was placed into the guide cannula.  A 
volume of 300 nl of the chemical of interest was then injected into the SCN over a period of 30 
sec.  The stylet was then replaced to maintain patency throughout the experiment.   
 For microdialysis perfusions, the mouse was removed from the cage prior to CT 12 and a 
probe (CMA Microdialysis) extending 2 mm below the guide cannula was inserted through the 
guide and attached to the animal using a head-block tether system (Harvard Apparatus).  
Animals were placed in a circadian activity monitoring system (CAMS) designated for these 
collections, in a cage without a wheel, and attached to fluid swivels (Harvard Apparatus) to 
allow free movement throughout the perfusion.  The probe was perfused continuously at a rate of 
1 µl/min with artificial cerebrospinal fluid (aCSF: 0.13 M NaCl, 4 mM KCl, 0.75 mM NaH2PO4 
[anhydrous], 2 mM Na2HPO4, 1 mM dextrose, 2 mM MgCl2, 1.7 mM CaCl2), until the 
appropriate CT, when the chemical of interest was prepared in aCSF and perfused through the 
probe.  Upon completion of the experiment, the mouse was unhooked from the probe and 
returned to the home cage and wheel for behavioral monitoring.   
 Unless otherwise stated, acute light pulses were administered for 5 min at 20 lux in a 
designated CAMS, while the microdialysis light pulses were administered for 10 min at 20 lux.  
The chemicals that were injected or perfused are as follows:  jasplakinolide (20 µM, Enzo Life 
Sciences, Plymouth Meeting, PA) and latrunculin A (100 µM, Calbiochem, Gibbstown, NJ).  
Both of these were dissolved in aCSF containing ≤0.05% DMSO for acute injections and ≤0.5% 
DMSO for microdialysis infusions.  Vehicle injections were composed of aCSF containing 
DMSO at the same concentration as that used in chemical treatments. 
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Histology 
 Upon completion of the experiment, the injection site was verified by injection of 300 nl 
of 0.1% thionin into the guide cannula or infusion of 0.1% methylene blue dye through the 
microdialysis probe at 1 µl/min for 20 min.  Mice were sacrificed, brains were sliced coronally 
and Nissl-stained with cresyl violet using standard procedures 177, and cannula placement was 
verified using light microscopy (Fig 3.1). 
Tissue collection and brain slicing 
 Light pulse experiments used mice in the early night (ZT 14 or CT 15).  Mice were 
removed from their home cage at ZT 14 under dim red light (~1 lux).  After receiving a light 
pulse, mice were sacrificed by cervical dislocation and brains quickly removed.  Whole brains 
were placed into powdered dry ice to immediately freeze the tissue, which was then stored at  
-80°C until being sliced.   For F-:G-actin separation experiments, SCN tissue was removed from 
these brains by sectioning whole brains into 160-µm sections using a cryostat.  The SCN were 
selectively removed from 4 of these slices using a 2-mm tissue punch and kept frozen until 
processing for actin content.  For phalloidin staining experiments, whole brains were sliced on a 
cryostat into 30-µm sections, mounted directly to slides, and kept frozen until being fixed in 4% 
paraformaldehyde for 30 min and allowed to dry for further staining. 
F-:G-actin separation assay and western blotting 
 For each sample, SCN-containing reduced slices from 3 mice were pooled.  One hundred 
µl of cell lysis buffer (20 mM HEPES pH 7.2, 100 mM NaCl, 1 mM sodium orthovanadate, 1% 
Triton X-100) containing protease inhibitor (Complete Protease Inhibitor Cocktail, Roche, 
Indianapolis, IN) was added to each sample and then samples were lysed by trituration.  Thirty-
five µl of this whole cell lysate was collected, spun briefly to remove cellular debris, and the 
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supernatant saved as the “total actin” sample.  The remaining cell lysate was centrifuged at 
10,000 x g for 20 min.  The supernatant, containing G-actin, was collected.  The pellet, 
containing F-actin, was then redissolved in RIPA buffer (50 mM Tris pH 8, 150 mM NaCl, 0.1% 
SDS, 1% NP40, 0.5% sodium deoxycholate) containing protease inhibitor (Complete Protease 
Inhibitor Cocktail, Roche) for 1 h, and then centrifuged again at 12,000 x g for 30 min.  This 
supernatant was collected as the F-actin fraction and the pellet was discarded.  Total protein 
content from each sample was determined using the Micro BCA Protein Assay (ThermoFisher 
Scientific, Waltham, MA). 
 Separated samples were resolved by western blotting.  Twenty-five µg of total protein 
from each sample was mixed with Laemmli buffer and denatured at 95°C for 5 min.  These 
samples were then separated by 8% SDS-PAGE and transferred to nitrocellulose (Biorad, 
Hercules, CA).  Following blocking in 5% milk, membranes were probed with anti-β-actin 
polyclonal antibody (Sigma, St. Louis, MO) overnight at 4°C.  As a loading control, blots were 
probed with anti-β-tubulin (Sigma).  Membranes were developed using Supersignal 
chemiluminescent substrate (ThermoFisher Scientific) and visualized using a Biochemi Imaging 
System (UVP, Upland, CA).  Levels of total, G-, and F-actin were determined using 
densitometry and compared to tubulin as a loading control. 
Phalloidin and DNase staining 
 Slides containing 30-µm sections of whole mouse brains were rinsed thoroughly to 
remove excess fixative.  After blocking in bovine serum albumin (BSA, Sigma) for 90 min, 
slides were incubated with rhodamine-phalloidin and Alexa-fluor 488-DNase (phalloidin: 2 
units/mL, DNase: 10 µg/mL, in 1% BSA/0.03% Triton X-100-PBS; Invitrogen, Carlsbad, CA) 
for 2 h at room temperature, and then slides were incubated with DAPI (0.2 µM, Invitrogen) for 
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5 min at room temperature.  Slides were coverslipped using Prolong Gold Anti-Fade solution 
(Invitrogen) and allowed to dry.  Staining was evaluated using a Zeiss Meta 510 LSM confocal 
microscope or a Nikon fluorescent microscope. 
 
Results 
Brief light exposure causes rearrangement of actin 
 In order to determine how light exposure affects actin state, mice received pulses of light 
for 1-2, 4, or 6 min at ZT 14, at which point the mice were sacrificed and whole brains collected 
by snap-freezing.  These were then kept frozen during sectioning and removal of the SCN, which 
was then analyzed by F- and G-actin separation in order to determine the F/G-actin ratio.  As 
controls, mice were collected at ZT 14 under dim red light, previously shown to cause no delay 
in rhythms (Arnold and Gillette, unpublished observations).  Using this technique, light exposure 
for 1-2 min induces significant decreases in the F-:G-actin ratio by 15% ± 6% compared to 
control animals (p < 0.05, Student’s t-test).  However, by 4 min, F-actin levels are not 
statistically different from controls (Fig. 3.2).  
 Changes in actin state were also evaluated using phalloidin and DNase staining.  By 
analyzing fluorescence intensity of these two compounds and comparing phalloidin:DNase, the 
F/G-actin ratio can be determined 153.  For this experiment, mice were placed in total darkness 
(D:D) for 3 days, upon which they received a 1-min light pulse at CT 15 and mice were 
sacrificed and whole brains snap-frozen.  As controls, mice were placed in D:D for 3 days and 
tissue was collected at ~CT 15 under dim red light.  Tissue was sectioned frozen and post-fixed 
before staining with rhodamine-conjugated phalloidin and Alexa Fluor-488-conjugated DNase to 
analyse actin state.  Utilizing this method, animals receiving light show a significant decrease in 
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F/G-actin of 3.52 ± 0.81% compared to control animals (Fig. 3.3, p < 0.05, Student’s t-test).  
These experiments indicate that a brief light pulse induces actin depolymerization in the SCN. 
Infusion of the actin depolymerizing compound latrunculin A induces phase delays in behavior 
 To examine the effects of direct F-actin depolymerization on running-wheel behavior in 
mice, the actin depolymerizing agent latrunculin A was infused through a microdialysis probe at 
a rate of 1 µl/min from ZT 13-14, after which mice were placed into constant darkness and onset 
of running-wheel behavior was analyzed for changes in phase.  Infusion of 100 µM Lat A 
resulted in a delay of 0.28 ± 0.10 hr, while infusion of vehicle (0.5% DMSO in aCSF) induced a 
delay of 0.004 ± 0.09 hr (Fig. 3.4, p < 0.05, Student’s t-test).  The delay induced by Lat A is not 
significantly different from the delay of 0.40 ± 0.15 hr induced by a 10 min, 20-lux light pulse at 
ZT14 (p = 0.84). 
Actin depolymerization is necessary for light-induced phase delays 
 In order to examine the necessity of F-actin depolymerization in the phase response to 
light, Jasp was administered directly to the SCN of freely behaving mice immediately before 
exposing the mice to light at CT 14.  Following treatment, mice were allowed to run for 10 days, 
and the onset in wheel-running was compared before and after treatment to assess changes in 
clock state (Fig. 3.5).  In these mice, a 5-min, 20-lux pulse of light at CT 14 elicited a 0.88 ± 0.08 
hr delay in wheel-running onset, while injection of vehicle (artificial CSF/0.05% DMSO) 
immediately before the light pulse resulted in a delay of 0.90 ± 0.14 hr.   In contrast, injection of 
vehicle alone, under dim red light with no light pulse following the injection, elicited a 0.14 ± 
0.07 hr delay.  Injection of 20 µM Jasp, in a vehicle of aCSF containing 0.05% DMSO, 
immediately before a light pulse resulted in a significantly attenuated delay of 0.55 ± 0.09 hr 
compared to light-pulsed controls (p < 0.05, Student’s t-test).  Twenty µM Jasp in vehicle 
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injected at CT 14 without a light pulse elicited a delay of 0.10 ± 0.12 hr.  These results suggest 
that stabilizing the actin cytoskeleton using Jasp can block the light-induced delay in the clock in 
vivo. 
 
Discussion 
 These findings further our evidence that actin dynamics are an important component of 
the light signaling pathway.  I have shown that a brief light pulse can induce significant changes 
in actin polymerization in the SCN, using two methods to measure actin state.  This supports the 
finding from our lab that glutamate exposure to SCN in a tissue chamber at CT 14 induces F-
actin breakdown.  However, the in vivo changes in actin are less robust than the in vitro changes 
previously generated in the laboratory using Glu.  One reason for this smaller change in actin 
state, a subset of animals that do not respond to short pulses of light, is examined in the 
appendix.   
 F/G-actin separation experiments with mice show that a very short pulse of light in the 
early night is enough to elicit a change in actin state, but that this change is very brief.  Indeed, 
after 4 and 6 min, no measurable difference in actin state can be measured, implying that the 
actin change is rapid and transient, and returns to basal levels before 4 min.  This is in contrast to 
in vitro data, where the decrease in F-actin is significant at 5 min.  This difference can possibly 
be accounted for by the differences in the mode of stimulation.  Glu is applied as a microdrop to 
the surface of the slice and must diffuse into SCN tissue in a chamber in vitro.  During light 
exposure of a whole, intact mouse in vivo, the signal is transmitted through the eye and along the 
optic nerve.  While Glu diffusion into SCN tissue is based on Fick’s Law of Diffusion, intact 
synaptic transmission is faster by a factor of 109  178, so activating neurons in the eyes of the 
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intact animal and then measuring changes in a transient state in the SCN cells will occur much 
more quickly.  Additionally, the tissue used for the original in vitro experiments was a reduced 
SCN “punch”, whereas in vivo experiments used whole animals, containing all neuronal 
connections intact.  It is possible that changes are smaller because of some form of inhibition in 
the whole brain system, whereas the SCN punches would contain only SCN cells and little 
extraneous tissue, and therefore allow larger changes to occur.  This phenomenon has been 
demonstrated previously in our lab, as Glu-induced changes in firing rate in recording 
experiments induces larger phase shifts than light-induced changes in wheel-running activity at 
the same time of day 23.  Nevertheless, light pulses for very brief periods seem to be able to 
induce statistically significant changes in F-actin state. 
 Rhodamine-phalloidin and Alexa-488-DNase staining of SCN tissue also yielded 
significant differences in actin state after brief light pulses.  As with the western-based method, 
the changes are much smaller than those seen using staining in vitro of a brain slice after Glu 
treatment.  Similar to the results presented in chapter 2, this staining technique also seems to 
yield smaller changes in F/G-actin than western-based methods.  In an attempt to increase the 
differences between controls and light-pulsed mice, the method of tissue collection for this study 
was different than the one used for the western-based F/G-actin experiment.  In this study, mice 
were placed into constant conditions of total darkness (D:D) for three days prior to tissue 
collection, and then a light pulse was administered at approximately CT 15, in order to increase 
the probability that each mouse responded to the brief (1-2 min) pulse of light.  The appendix 
section of this dissertation discusses the importance of this technique further.  Using this 
collection method, staining results show a small but significant decrease in the ratio of 
phalloidin:DNase staining, indicating a decrease in the F/G-actin ratio. 
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 A second result from this study also matches findings in vitro.  When actin is 
depolymerized by direct infusion of Lat A into or near the SCN of a mouse, the onset of wheel-
running is significantly delayed compared to a vehicle infusion.  This follows previous work 
from the lab using rat brain tissue, in which bath application of Lat A from CT 12-14 induced a 
delay in peak firing rate that was of the same magnitude as the delay induced by Glu application 
130.  In vitro work also included actin depolymerization using a second compound, Cyto D.  Bath 
application of this compound to rat SCN slices also induced Glu-like delays in peak firing rate.  
Intra-SCN injections with this chemical were not able to induce changes in the clock.   
 This discrepancy may be due to the different ways in which the two chemicals act to 
break down F-actin.  Cytochalasins, compounds isolated from fungi, act by binding to the 
growing end of the actin filament (the barbed end), preventing further polymerization, and 
therefore eventually resulting in a decreased level of F-actin 179, 180.   On the other hand, 
latrunculins, which are produced by sea sponges, bind to G-actin monomers in a 1:1 ratio, 
preventing the formation of further polymers 181.  It is possible that in order to sufficiently 
depolymerize actin, a higher concentration of Cyto D is need in vivo than for Lat A.  It is also 
possible that longer exposure to the chemical is needed, due to differences in cell permeability of 
the two compounds.  Regardless, using Lat A to break down F-actin in the SCN results in a 
phase delay, indicating that directly depolymerizing the actin cytoskeleton is sufficient to induce 
a delay in clock phase.   
 The final result from this study suggests that actin depolymerization is required for the 
phase delay induced by light in early night.  Jasplakinolide is a peptide isolated from a sea 
sponge that binds strongly and selectively to F-actin and prevents its depolymerization 182.  
When Jasp is injected directly into mice at CT 14, either into or near the SCN, the delay in 
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wheel-running onset induced by light is significantly attenuated.  This follows in vitro results, in 
which pre-incubation of SCN slices with Jasp blocked the Glu-induced delay in peak time of 
extracellular activity recordings.  Although delays in running-wheel onset were not completely 
blocked like those in recordings, the results are still significant.   
 The differences can be accounted for by several factors.  First, the method of delivery is 
different.  For electrophysiology, Jasp is administered to the SCN tissue by bath application.  
Jasp is dissolved in tissue culture media and this is placed into the tissue chamber, completely 
surrounding the small slice of brain, for 20-30 min before adding glutamate.  For in vivo 
delivery, Jasp is injected through a cannula into a living brain.  This limits the volume of liquid 
that can be delivered, and therefore the amount of Jasp that the mouse receives.  Also, bath 
application of Jasp allows for continuous delivery of the chemical to the brain slice during the 
treatment, while an injection delivers a bolus of chemical all at once.  In the living brain, 
extracellular fluid or cerebrospinal fluid is constantly circulating.  The liquid injection delivered 
to the animal is likely quickly diffused in the tissue, so that Jasp is not able to get into cells and 
bind to actin as well.  Finally, as discussed above, the mode of transmission of light and 
glutamate are different, and this likely affects how Jasp works to block the phase delay.  A light 
pulse is given to the mouse immediately following the acute injection of Jasp, while Glu is 
delivered to a brain slice while it is still exposed to the bath application of Jasp.  Because of this, 
it is possible that the effects of stabilizing actin are not present throughout the entire light pulse, 
which could account for the incomplete blockade of the delay in vivo. 
 A second factor that may account for the smaller attenuation by Jasp in vivo is the 
injection technique.  The implanted cannula is aimed at one SCN in the mouse brain, so that 
during an injection, Jasp should only be administered to the cells on one side of the brain.  This 
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likely accounts for the partial inhibition of the light pulse’s effects.  However, for this study, the 
data from mice in which the cannula was implanted into the 3rd ventricle, at the level of the optic 
chiasm, was also included.  Therefore, bilateral exposure is possible.  Again, though, injection 
into the ventricle, which contains a large volume of CSF, dilutes the compound further, and so 
exposure of Jasp to the SCN is still limited. 
 These results, combined with the in vitro studies previously undertaken in the laboratory, 
demonstrate the involvement of transient actin dynamics in mediating light-induced delays of the 
clock in early night. 
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Figures 
 
 
 
 
 
 
 
 
 
Fig. 3.1 Validation of cannula placement in intra-SCN surgeries in mouse.  The cresyl-violet 
dye track is clearly visible in these Nissl-stained hypothalamic slices (50 µm).  A-B: acute 
cannula, C-D: microdialysis probe.  Scale bar = 500 µm. 
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Fig. 3.2 Light induces a transient decrease in F-actin.  Light pulses of 1-2 min induce a 
decrease in the F-:G-actin ratio of 15 ± 6% relative to non-light pulsed controls (0 min).  Tubulin 
levels do not change and are used as a loading control.  n = 14 for 0, n = 12 for 1-2 min, n = 6 for 
4 and 6 min, * p < 0.05, Student’s T-test (0 vs 1-2 min). 
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Fig. 3.3 Light induces a decrease in F/G-actin ratio by staining.  Light pulses of 1-2 min 
induce a decrease in the ratio of F-actin (rhodamine-phalloidin, red) to G-actin (Alexa-488 
DNase, green) of 3.52 ± 0.81% compared to control animals (DD).  DAPI staining (blue) was 
used to define the borders of the SCN.  n = 7, p < 0.05, Student’s t-test, scale bar = 100 um.  
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Fig. 3.4 Direct actin depolymerization in vivo induces phase delays.  A 10 min, 20-lux LP at 
ZT 14, after which the mouse was placed into total darkness, resulted in a delay in wheel-running 
of 0.40 ± 0.15 hr.  Infusion at a rate of 1 µl/min into or near the SCN of 100 µM latrunculin A 
(Lat A) induced a delay of 0.28 ± 0.10 hr, while infusion of vehicle (0.5% DMSO in aCSF) 
resulted in a delay of 0.004 ± 0.09 hr.  Yellow arrow indicates time of light pulse, green box 
indicates infusion times, n = 7, * p < 0.05, Student’s t-test (vehicle vs Lat A).  
LatAVehicleLP
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Fig. 3.5 Stabilizing the cytoskeleton in vivo attenuates the light-induced delay of the clock.  
Injection of vehicle (0.05% DMSO/aCSF) at CT 14 elicited a delay in onset of wheel-running of 
0.14 ± 0.07 hr, while injection of 20 µM jasplakinolide (Jasp) induced a delay of 0.10 ± 0.12 hr.  
Injection of vehicle followed by a 5 min, 20-lux light pulse (LP) elicited a delay of 0.90 ± 0.14 
hr.  Injection of Jasp immediately followed by a 5 min, 20-lux LP caused a delay of 0.55 ± 0.09 
hr.  LP alone induced a delay of 0.88 ± 0.08 hr. Yellow arrows indicate time of treatment, n = 8, 
* p < 0.05, Student’s t-test (Jasp + LP vs vehicle + LP, vs LP, and vs Jasp), ** p < 0.01, 
Student’s t-test (Jasp + LP vs vehicle). 
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CHAPTER FOUR 
ACTIN CHANGES IN THE SCN ENGAGE DOWNSTREAM EFFECTORS OF CLOCK 
STATE 
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Abstract 
 
In the circadian system, light exposure in the night activates a signaling pathway through 
glutamate resulting in upregulation of the clock genes, Period 1 and Period 2.  This upregulation 
is mediated in part through cAMP response elements (CREs), through activation of the 
transcription factor, cAMP response element binding protein (CREB), which itself is activated 
by MAP kinase activity.  In Chapter 3, I provided evidence that transient actin depolymerization 
is required for early night light signaling, but a connection between these cytoskeletal changes 
and known downstream transcriptional events has not been found.  In this study, I found that 
treatments depolymerizing F-actin significantly increase the level of activated phospho-ERK, a 
component of the MAP kinase pathway.  Depolymerizing F-actin also resulted in a trend of 
increased phospho-CREB.  When CRE-mediated transcription was blocked in SCN slices, 
latrunculin A-induced delays in the clock were blocked, indicating a role for actin-mediated 
regulation of CREB.  Finally, treatments that depolymerize F-actin significantly induce PERIOD 
2 (PER2), as measured by the clock-gene reporter, PERIOD2::LUCIFERASE.  Stabilizing actin 
with Jasplakinolide (Jasp) blocks the Glu-induced rise in PER 2.  This study supports a role for 
actin dynamics in mediating transcriptional changes in the central circadian clock. 
 
Introduction 
 The suprachiasmatic nucleus (SCN) in the ventral hypothalamus houses the central 
circadian clock in mammals.  The cells of this pair of nuclei keep time endogenously, and the 
phasing of the time base can be reset in order to align the internal clock of the animal with the 
external environment.  The most important environmental signal to reset the clock is light.  Light 
from the eyes signals the cells of the SCN through glutamate (Glu), and the signaling pathway 
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that is activated results in a change of clock phase that is time-of-day dependent.  In the early 
subjective night, light induces a delay of the clock.  At this time, activation of the glutamate-
mediated signaling pathway has been shown to increase expression of the clock genes, Period 1 
(Per1) and Period 2 (Per2) 36, 183. 
 Connecting glutamate release with these transcriptional changes is a series of signaling 
components, many of which have been characterized, though some remain unidentified.  In the 
early night, NMDA receptor activation by Glu results in a series of signaling events that include 
nitric oxide production and consequent activation of ryanodine receptors within the cell 23, 71.  
The calcium (Ca2+)-induced Ca2+ release that accompanies the activation of these receptors 
induces a transient rearrangement of the actin cytoskeleton and activation of a MAP kinase 
pathway.  Results from chapter 3 indicate that the actin breakdown is required in order for a 
light-induced phase delay to occur.  It is not currently known, however, how changes in actin 
could mediate downstream transcriptional effects that underlie the phase delay.  In this study I 
will address this issue. 
 In mammals, two period genes, Per1 and Per2, have been found to be involved in light 
signaling.  Light pulses in the night induce rapid expression of Per1 mRNA, peaking around 30 
min after light exposure.  This induction of Per1 is seen in both early and late subjective night, 
but not in subjective day.  Expression of Per2, on the other hand, is much slower, with increases 
seen 3 h after light exposure 36, 183.  Also, induction of Per2 is restricted to light exposure in the 
early subjective night 35.  Expression of Per1 has been found to be required for light-induced 
phase advance, as knockdown of Per1 using antisense oligodeoxynucleotides (ODN) blocks the 
light and glutamate-induced changes in the clock 184.  Also, mice containing a mutant Per1 do 
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not advance after a light pulse in late night.  Conversely, Per2 mutant mice do not delay in early 
night after a light pulse, indicating a requirement for Per2 in early night phase delay 185. 
 Both period genes contain at least one CRE sequence within their promoters 91.  This 
sequence binds the activated transcription factor PCREB, mediating gene expression for a wide 
range of physiological processes, including long-term potentiation and memory formation, 
spermatogenesis, and pituitary function 186.  In the SCN, PCREB induction is seen within 5 min 
of a light pulse at night 87, as well as due to application of several of the known components of 
the light signaling pathway, including Glu 88, 187, and NO donors 88.  Additionally, PCREB is 
induced in JEG-3 cells transfected with mPer1 or mPer2 promoters containing a luciferase 
transcriptional reporter upon addition of 12-o-tetradecanoylphorbol 13-acetate (TPA), which 
activates MAPK and its downstream targets, including PKA 91.  PCREB has been shown to bind 
to the promoters of both Per1 and Per2 91, supplying additional support that PCREB mediates, at 
least in part, the transcription of these genes as a response to light exposure in the night. 
 One activator of CRE-mediated transcription is the mitogen activated kinase (MAPK) 
pathway 84, 188.  This pathway has been found to be induced by light or Glu in early night 82.  
Extracellular-signal regulated kinases (ERKs), kinases of the MAPK cascade, are phosphorylated 
within 5 minutes of light exposure at CT 15 82.  Inhibition of MAPK/ERK Kinase (MEK) by 
intracerebroventricular application of the inhibitors U0126 or PD98059 attenuates the light-
induced delay in early night in behavior, indicating a role for ERK in mediating phase delays 78, 
83.  MAP Kinases have been found to lie downstream of both CAMKII and Glu-induced Ca2+ 83, 
84, but their specific position within the light signaling pathway has yet to be established. 
 In this chapter, I present evidence that actin depolymerization can induce activation of 
ERK, and a trend toward induction of the active form of CREB.  Additionally, I demonstrated 
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the requirement of actin remodeling for CRE-mediated transcription.  Finally, I show that actin 
depolymerization can increase PERIOD 2 levels.  These experiments utilize a transgenic mouse 
that contains a modified Period 2 gene encoding the PERIOD 2 protein fused to luciferase, 
resulting in a PER2::LUC reporter 189.  By measuring luciferase activity, PER 2 abundance can 
be tracked and quantified.  These experiments will provide the first evidence that actin 
rearrangements in the SCN mediate the transcriptional changes required for a light-induced 
phase delay in the early night. 
 
Materials and Methods 
Animals and circadian time 
 Male C57Bl/6 mice 6-12 weeks of age, obtained from Jackson Laboratories (Bar Harbor, 
ME) were used for this study.  Mice containing a transgene that encodes PER 2 fused to 
luciferase (PER2::LUC mice) were obtained from Jackson Laboratories and bred in-house.  For 
recording experiments, 6-12 week old Long Evans/BluGill rats were used (University of 
Illinois).  These rodents are housed under standard conditions in 12-h light:12-h dark (L:D) 
cycles or constant darkness (D:D) and given food and water ad libitum.  All animals are housed 
and cared for in full compliance with NIH guidelines for the humane treatment and care of 
animals and animal protocols have been approved by IACUC at the University of Illinois. 
Tissue collection and treatments 
 Mice are sacrificed before ZT 10 by cervical dislocation and brains quickly removed.  A 
block of tissue containing the hypothalamus was made and then a 500-µm slice containing the 
SCN was isolated using a tissue chopper.  For biochemical analysis, the SCN was then removed 
from these slices using a 2 mm tissue punch and this was placed into a brain slice chamber.  
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Slices were perifused continuously with Earle’s balanced salt solution (EBSS) supplemented 
with 24.6 mM glucose, 26.2 mM sodium bicarbonate and 5 mg/L gentamicin and saturated with 
95% O2 / 5% CO2.  At the designated CT, treatments were applied one of two ways:  1) Glu (10 
mM) was applied directly to the SCN as a 2-µl microdrop; 2) actin-altering chemicals and CRE-
decoy were applied as a bath application: latrunculin A (1 µM; Calbiochem, Gibbstown, NJ), 
cytochalasin D (0.1 µM; Calbiochem), jasplakinolide (2 µM; Enzo Life Sciences, Plymouth 
Meeting, PA), CRE-decoy (1 µM, Operon, Huntsville, AL).  Reduced slices were collected by 
snap-freezing on dry ice, and kept at -80°C until further processing. 
Western blotting 
 For each sample, 2 SCN-containing reduced slices were used for each N.  Seventy-five µl 
of RIPA buffer (50 mM Tris pH 8, 150 mM NaCl, 0.1% SDS, 1% NP40, 0.5% sodium 
deoxycholate) containing protease (Complete Protease Inhibitor Cocktail, Roche, Indianapolis, 
IN) and phosphatase inhibitors (EMD Chemicals, Gibbstown, NJ) was added to each sample and 
then samples were lysed by trituration.  Samples were spun at 10,000 rpm for 5 min and the 
supernatant was saved in a fresh tube.  Total protein content from each sample was determined 
using the Micro BCA Protein Assay (ThermoFisher Scientific, Waltham, MA). 
 Samples were resolved by western blotting.  Twenty-five to thirty µg of total protein 
from each sample was mixed with Laemmli buffer and denatured at 95°C for 5 min.  These 
samples were then separated by 8% SDS-PAGE and transferred to nitrocellulose (Biorad, 
Hercules, CA).  Following blocking in 5% milk, membranes were probed with anti-phospho-
CREB (PCREB, Ser133) antibody (Upstate, Billerica, MA) or anti-phospho-p42/p44 (PERK) 
antibody (Cell Signaling Technology, Danvers, MA) overnight at 4°C.  As controls, blots were 
probed with anti-CREB (made in-house) or anti-p42/p44 (ERK, Cell Signaling Technology). 
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Membranes were developed using Supersignal chemiluminescent substrate (ThermoFisher 
Scientific) and visualized using a Biochemi Imaging System (UVP, Upland, CA).  Levels of 
PCREB or PERK were determined using densitometry and compared to CREB or ERK, which 
show no changes between treatments. 
Luciferase assays 
 Hypothalamic slices or reduced slices containing the SCN were collected following 
treatment and immediately frozen in dry ice.  Each slice was lysed by trituration in 100 µl of cell 
culture lysis reagent (Promega, Madison, WI).  Lysates were centrifuged for 5 min at 10,000 rpm 
and the supernatant was saved in a fresh tube.  Sixty µl of this lysate was then placed in one well 
of a white 96-well microlite 2+ plate (ThermoFisher Scientific) and PER2::LUC levels were 
measured in a luminometer (Luminoskan, MTX Lab Systems, Vienna, VA).  Total protein levels 
in each sample were evaluated using a BCA Protein Assay Kit (ThermoFisher Scientific) and 
luminescence in relative light units was normalized to total protein for each sample. 
Electrophysiology 
 Spontaneous firing rhythms were assessed in SCN brain slices using a single unit activity 
recording technique 28.  Mean firing rate for an individual cell was measured over a period of 4 
min, and these were then grouped into 2-h running averages with a 15-min sliding window.  
Average firing rate was plotted against the circadian time of recording, and time-of-peak for each 
experiment was determined from this plot for the highest firing rate.  Phase shifts were assessed 
by comparing time-of-peak for each treatment experiment with that of the mean of vehicle-
treated control experiments. 
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Results 
Actin depolymerization induces activation of the MAP Kinase pathway 
 To evaluate the effect of actin depolymerization on activation of downstream signaling 
elements, SCN tissue was treated with a continuous bath application of 1 µM latrunculin A (Lat 
A) at CT 15 and collected 5, 15, 30, and 60 min after the start of treatment on dry ice.  As a 
control, tissue was collected at CT 15 immediately prior to Lat A treatment.  Tissue was 
analyzed using western procedures probing for anti-phospho-p42/p44 (PERK).  In this study, 
actin depolymerization induced PERK formation within 5 min, with a 33 ± 5 % increase that 
peaked at 15 min after the start of exposure to Lat A with a 46 ± 7 % increase.  Thirty minutes 
after beginning Lat A exposure, PERK continued to be induced by 45 ± 11 %, returning to basal 
levels by 60 min (Fig. 4.1, p < 0.001, ANOVA with Dunnett’s post-test).  These results indicate 
that the MAP kinase pathway is activated by F-actin breakdown in the SCN. 
Actin depolymerization may alter PCREB 
 To evaluate the effect of actin dynamics on CRE-mediated transcription, SCN tissue was 
treated with a continuous bath application of 1 µM Lat A at CT 15 and collected on dry ice 5, 15, 
30, and 60 min after the start of treatment.  As a control, tissue was collected at CT 15 before Lat 
A treatment began.  Tissue was then analyzed for induction of PCREB using western procedures, 
probing for anti-Ser-133-phospho-CREB antibody.  Using this technique, depolymerization of 
the actin cytoskeleton with Lat A trended toward a 19.2 ± 5.8 % increase in phospho-CREB at 
30 min (Fig. 4.2, p = 0.0822, Student’s t-test).  
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CRE-mediated transcription is mediated through actin dynamics 
 In order to physiologically connect actin dynamics to transcriptional changes in the SCN, 
I used a CRE oligodeoxynucleotide (CRE-decoy) to examine whether CRE-mediated 
transcription plays a role in actin-based signaling in the SCN.  CRE-decoy was preincubated (1 
h, CT 14-15) with rat SCN slices in early subjective night, and then these slices were co-
incubated with the actin destabilizer, Lat A (1 h, CT 15-16).  As previously observed, Lat A 
alone induced a 2.42-hr delay in peak firing rhythm compared to control (peak time = CT 9.08 ± 
0.22 vs. CT 6.67 ± 0.08, respectively) when administered to slices from CT 15-16.  CRE-decoy, 
applied from CT 14-16, effectively blocked this Lat A-induced delay in firing rhythms in rat 
(peak time = CT 6.75 ± 0.25).  CRE-decoy alone did not affect timing (peak time = CT 6.92 ± 
0.08). (Fig 4.3, p < 0.0001, 1-way ANOVA with Dunnet’s post-test, n = 3.) 
Actin depolymerization induces an increase in PER 2 
 In order to examine how the actin cytoskeleton affects Per2 expression, SCN slices from 
mice containing the gene encoding the PER2::LUC fusion protein were treated with actin-
rearranging chemicals and analyzed for luciferase activity.  When 10 mM Glu or 0.1 µM 
cytochalasin D (Cyto D), an actin depolymerizing agent, were added to slices, luciferase activity 
increased 1.32 ± 0.20-fold and 1.64 ± 0.18-fold after 6 h, respectively, compared to EBSS-
treated controls.  This indicates that PER 2 levels are increased by these treatments.  Conversely, 
when these slices were pre-incubated with Jasp, which stabilizes F-actin, Glu treatment did not 
induce luciferase activity (0.85 ± 0.13-fold vs. control), while a preliminary control experiment 
with Jasp treatment alone also did not induce luciferase activity (0.52-fold). (Fig 4.4, p < 0.05, 1-
way ANOVA with Dunnett’s post-test)  
 
 68 
 
Discussion 
 The results of this study provide further evidence that the actin dynamics shown in 
chapter 3 are an important component of the light signaling pathway.  Direct actin 
depolymerization induces ERK activation, an important step in the MAP kinase signaling 
pathway.  This suggests that changes in actin state occur upstream of MAPK pathway activation.  
Prior to this study, MAP kinase elements were found to lie downstream of Ca2+ influx 84.  The 
findings in this chapter continue to support this position for MAPK in the signaling pathway. 
 Additionally, Lat A-induced F-actin breakdown resulted in an increase in the active form 
of CREB, PCREB.  Though not statistically significant, this result is suggestive of actin’s 
regulation of CRE-mediated transcription.  As with PERK, the neurons of the hippocampus that 
undergo actin changes after activation also show increased PCREB, which is linked to increased 
expression of several genes important for the consolidation phase of long-term potentiation 106, 
107.  A second result that supports the role of actin in the regulation of CRE-mediated 
transcription was found using electrophysiological recordings of SCN slices.  When the CRE-
decoy is incubated in SCN slices, activated CREB and other CRE-binding proteins will bind to 
the decoy oligodeoxynucleotide molecules, essentially serving as a blocker of transcription that 
is mediated through CRE 89.  When this decoy was preincubated with the SCN slice before and 
during Lat A application, the delay in peak firing rate that is caused by Lat A was blocked.  This 
implies that Lat A works to induce a delay in the clock through CRE-mediated transcription.  
These two experiments together also suggest that the changes in actin state are upstream of 
activation of CREB.  Because ERK activation, which is upstream of CREB activation, is induced 
by actin depolymerization, and the MAPK pathway is one regulator of CREB 84, 188, these 
conclusions are plausible. 
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 A final study examined PERIOD 2, a protein that is upregulated following light exposure 
in early night 35, 36.   This study found that direct actin depolymerization results in an 
upregulation of PER 2, an important event in the early night for a light-induced phase delay.  
This supports previous findings from our lab, in which per2 mRNA was found to increase 2 hr 
after treatment of rat SCN with Cyto D, measured by qPCR (Kandalepas and Gillette, 
unpublished).  Additionally, pre-incubation of rat SCN tissue with Jasp, followed by treatment 
with Glu, blocked the induction of per2 seen with Glu exposure (Mitchell and Gillette, 
unpublished), and pre-incubation of SCN tissue with Jasp blocked the Glu-induced rise of PER 2 
(Fig. 4.4).  The findings from this study, which evaluated PER 2 protein, corroborate these 
earlier findings examining mRNA.  Taken together, this data indicates that actin dynamics play 
an important role in transcriptional regulation of the clock. 
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Figures 
 
 
 
 
 
 
 
Fig. 4.1 F-actin depolymerization induces MAPK signaling.  Treatment of SCN reduced 
slices from mice from CT 15-16 with latrunculin A (Lat A) significantly increased PERK at 5 
(1.33 ± 0.05-fold), 15 (1.46 ± 0.07), and 30 (1.45 ± 0.11) min following start of treatment.   
PERK levels returned to basal levels by 60 min.  n = 3, p < 0.001, 1-way ANOVA with Dunnet’s 
post-test. 
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Fig. 4.2 F-actin depolymerization may alter PCREB levels.  Treatment of SCN reduced slices 
from mice from CT 15-16 with latrunculin A (Lat A) resulted in a trend toward an increase in 
PCREB by 1.19 ± 0.06 – fold at 30 min following start of treatment.   n = 3, p = 0.0822, 
Student’s t-test, 0 vs. 30 min. 
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Fig. 4.3 Actin dynamics regulate CRE-mediated transcription.  Control, untreated SCN slices 
from rat show a peak in spontaneous neural activity at circadian time (CT) 6.67 ± 0.08).  1-h bath 
application of the actin-destabilizer latrunculin A (Lat A) from CT 15-16 induces a 2.42-h delay 
(peak time = 9.08 ± 0.22).  Incubation with CRE-decoy (from CT 14-16) blocks the phase-
delaying effects of Lat A incubation (CT 15-16, peak time = 6.75 ± 0.25), while CRE-decoy 
alone does not shift the time of peak in this preliminary experiment (peak time = 6.92 ± 0.08).   
n = 3, p < 0.0001, 1-way ANOVA with Dunnet’s post-test. 
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Fig. 4.4 Actin dynamics influence clock gene expression in the SCN.  Treatment of an SCN 
brain slice from mouse at CT 14 with Glu increases PER 2 expression by 1.32 ± 0.20-fold at 6 hr 
from the start of treatment, while cytochalasin D (Cyto D) induces a 1.64 ± 0.18-fold increase in 
PER 2 at 6 hr.  Pre-incubation with the actin stabilizer jasplakinolide (Jasp) blocks the Glu-
induced increase of PER 2, with a 0.85 ± 0.13-fold induction 6 hr later.  A preliminary 
experiment found that Jasp alone does not increase PER 2 levels.  n = 5 control, n = 4 Glu, n = 2 
Cyto D and Jasp + Glu, n = 1 Jasp.  * p < 0.05, ANOVA with Dunnett’s post-test. 
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CHAPTER FIVE 
SUMMARY AND CONCLUSIONS  
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 Actin has been implicated in an ever-growing list of physiological roles.  As the main 
component of contractile cells, actin has long been known to be critical for muscle function.  It is 
also ubiquitous in the cytoplasm of all eukaryotic cells, forming microfilaments of the 
cytoskeleton, a function that allows for the overall shape and integrity of cells to be maintained.  
Until recently this scaffolding was thought to do little more than support.  More recently, 
however, the actin cytoskeleton has been shown to be highly dynamic, allowing for a wide 
variety of cell types to respond to various environmental and intracellular responses, several of 
which are reviewed below. 
 In many motile types of cells, such as the protozoa species of Amoeba and Euglena, as 
well as immune cells such as macrophages, actin rearrangements are responsible for movement.  
F-actin polymerization occurs at the leading edge and depolymerization occurs at the lagging 
edge, propelling the cell forward.  This allows the cell to move toward chemoattractant 
substances it encounters in the environment 122, 137. 
     Shape changes due to actin rearrangements are also important in the cells of the 
hippocampus.  When the dendrites of these neurons are activated by glutamate, a series of 
signaling events leads to increased polymerization of actin in the dendritic spines, which 
increases their size to allow for more contact with the stimulating cell.  This is one step in the 
formation of new memories 115, 116. 
 The microfilament scaffold is also involved in signaling.  In rat hepatoma cells, a signal 
of oxidative stress is mediated through actin.  When the stressor activates surface receptors and 
subsequent downstream signaling molecules, actin is depolymerized, which releases a bound 
protein, Keap 1.  Upon release from actin, Keap 1 relinquishes its hold on the transcription factor 
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Nrf2.  Nrf2 then translocates to the nucleus where it mediates transcription of important factors 
that aid in the response to oxidative stress 123, 124. 
 Yet another function of the actin cytoskeleton has been demonstrated in secretory cells, 
such as chromaffin cells in the adrenal medulla, β cells in the pancreas, and magnocellular 
neurons of the supraoptic nucleus.  These cells have been shown to release their vesicles of 
peptide hormone upon rapid and transient actin depolymerization occurring just beneath the cell 
membrane at the edge of the cell.  This actin “net” is thought to block vesicles from reaching the 
plasma membrane until a releasing stimulus, regulating release of hormone from the cell 125, 128, 
129.  In these experiments, stabilization of actin by jasplakinolide (Jasp) can block vesicular 
release 125, while disruption of F-actin by latrunculin A (Lat A) or cytochalasin B (Cyto B) can 
induce hormonal secretion 125-128, suggesting actin’s importance in secretion. 
 The data presented in this dissertation demonstrate a role for actin dynamics in the 
circadian clock within the hypothalamic suprachiasmatic nucleus (SCN).  In chapter 2 I show 
that actin state oscillates in mouse SCN in a circadian fashion, which is dependent on a 
functioning molecular clock.  A variety of signaling components oscillate, suggesting a role in 
signaling at specific times of the day.  In the SCN, light in early night induces a specific set of 
signaling components, ultimately resulting in a delay of the clock.  F-actin levels are highest in 
the SCN during early night, allowing for a robust depolymerization of the cytoskeleton at this 
time of the day-night cycle.  Loss of this oscillation in actin state in BMAL1 null mice may 
implicate the molecular clock’s regulatory role in actin state.  However, further studies may be 
needed to fully characterize this regulatory mechanism.  The use of another arrhythmic model 
would strengthen the finding.  Additionally, identification of the signaling elements that directly 
mediate the change of actin polymerization state have yet to be elucidated.  The number of 
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proteins that are known to bind to or indirectly regulate actin polymerization state is very large, 
and likely one or more of these compounds is directed by the clock to mediate actin state.  Until 
these are identified, the main conclusion that can be made about the regulation of actin state is 
that functional BMAL1 is necessary for the circadian oscillation. 
 In chapter 3, I show that light exposure induces a rapid and transient decrease of F-actin, 
strengthening previous in vitro results from the lab.  When this change in actin state is prevented 
by direct exposure of the SCN to Jasp, the delay induced by light in the onset of wheel-running is 
significantly attenuated.  A delay can be induced by application in vivo of the actin 
depolymerizing agent Lat A.  These results also complement in vitro findings from the lab on the 
effects of glutamate in the SCN brain slice.  The requirement for a rapid and transient change of 
actin state is reminiscent of the secretory cells of the SON.  Both the SCN and the SON are 
highly peptidergic, releasing peptides after stimulation in order to affect a downstream 
physiological target 190, 191.  While actin changes in the SON have been shown to occur at the 
cortex of the cell, the intracellular location of actin changes in the SCN have not yet been 
identified.  These neurons are some of the smallest in the brain, with an average soma size of 5-
15 µm, 10,000 of which are packed into each dense nucleus.  Together with the extensive glial 
network in the SCN 16, 192, this prevents easy visualization of individual cells in the SCN, 
compared to the large cells of the SON.  Thus, identifying the specific intracellular location of 
actin change in the SCN is difficult.   
 An alternative possibility for actin changes in the SCN is that the breakdown of actin 
releases a bound protein, which, upon release, mediates further signaling events.  Precedence for 
this is seen in rat hepatoma cells, in which actin depolymerization as a result of oxidative stress 
results in untethering of a transcription factor, Nrf2, which directly mediates expression of 
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effector genes 123, 124.  In chapter 4, I showed that light-induced actin rearrangements in the SCN 
induce activation of components of the MAP Kinase pathway and CRE-mediated transcription.  
Other possible components of this pathway downstream of actin have not been identified, but it 
is possible that one or more molecules could bind actin or an actin-binding protein.  Upon the 
transient breakdown of the cytoskeleton, these would be released from actin and act on further 
signaling machinery to mediate the activation of MAPK.  Work is being undertaken in the lab to 
identify F-actin-bound proteins that decrease their binding to actin upon Glu stimulus. 
 A third explanation for the changes in actin state is provided by the intense study of the 
neurons of the hippocampus.  In these cells, actin rearrangements result in a change of shape of 
the dendrites, which, in these cells, is important for increasing synaptic strength during formation 
of memory.  My results with light stimulation, as well as those previously established using Glu, 
indicate that activation of the light signaling pathway decreases F-actin polymerization in the 
SCN.  These changes were measured in whole SCN, including all cells in the nuclei.  These 
results do not provide any information about the cell type or location of the actin change.  As 
mentioned before when discussing the SON cells, examining individual cells in the SCN is 
difficult due to their small size and high density.  Consequently, it is not known where in the 
cells actin changes are occurring, or if light or Glu stimulation results in any change of shape in 
the SCN cells.  Clearly, localizing the changes in actin state within cells will provide valuable 
information. 
 In chapter 4, I began to explore the effects that actin rearrangements have on downstream 
events in the SCN cells.  By inducing actin filament breakdown using Lat A, I showed an 
increase in ERK phosphorylation, as well as a trend toward an increaes in PCREB.  I also 
blocked the Lat A-induced delay in the clock using CRE-decoy.  These experiments demonstrate 
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that actin changes in the cells are activating signaling events with known effects on transcription 
82, 84, 90, 91.  The final experiment in this chapter shows an increase in PER 2 upon cytoskeletal 
breakdown using Cyto D, while stabilization of F-actin using Jasp prevented the Glu-induced 
rise in PER 2.  This work supports previous findings from the lab that direct actin 
depolymerization by Cyto D induces per2 mRNA, while stabilization by Jasp blocks the Glu-
induced rise in per2 mRNA.   These findings are the first demonstration that actin remodeling 
directly affects clock gene expression.  These experiments examined the clock gene Per2, which 
is involved only in early-night light signaling 35, 36.  The specificity of Per2 to the early night 
makes it an attractive target for actin dynamics, but the effects of actin dynamics on other clock 
genes cannot be ruled out. 
 This study has contributed new information about the role of actin in light signaling, but 
further work remains in order to understand this process.  As mentioned previously, isolating the 
intracellular location of actin change in the SCN cells is a critical future experiment.  Once the 
location of actin change within the cells is known, predictions about the regulation of the actin 
state as well as possible downstream effectors can be made. 
 Another potential study is to examine other cytoskeletal changes in the SCN.  The 
findings in this work measured actin state, but many other types of cytoskeletal proteins also play 
important roles in various cell functions.  Microtubules, composed of tubulin, are one example.  
These structures play a role in the cell cycle, during spindle formation in mitosis, as well as in 
axonal transport and as a structural component of cell structures such as cilia.  Melatonin, 
another important modulator of clock phase, has been shown to induce changes in microtubule 
structure, both inducing polymerization and depolymerization depending on the presence or 
absence of calcium (Ca2+), respectively 193.  Conversely, microtubule breakdown regulates 
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melatonin receptors by enhancing their function and preventing desensitization 194-196.  
Interestingly, another study from the Gillette lab found changes in actin state mediated by 
melatonin, which are required for the melatonin-induced advances in the clock 197.  If melatonin 
induces changes in both tubulin and actin, it is possible that Glu does, as well.  This is just one 
example of a potential future study of the cytoskeleton.  Neurofilament and glial fibrillary acidic 
protein (GFAP) are two types of intermediate filaments in the brain 198, and how these 
cytoskeletal elements participate in signaling or in clock function needs to be examined. 
 Figure 5.1 summarizes the light signaling pathway in early night.  While many advances 
have been made to identify the factors involved in this pathway, clearly, much work remains. 
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Fig. 5.1 Early night light signaling induces phase delays of the clock.  RHT = 
retinohypothalamic tract, Glu = glutamate, NMDA-R = N-methyl-D-aspartate receptor, Ca2+ = 
calcium (i denotes intracellular), NOS = nitric oxide synthase, NO = nitric oxide, Ry-R = 
ryanodine receptor, PERK1/2 = phosphorylated extracellular-signal regulated kinases 1 & 2, 
PCREB = phosphorylated cAMP response-element binding protein, CRE = cAMP response 
element, Per1/2 = Period 1 and Period 2.   
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APPENDIX 
LIGHT PULSE LENGTH DETERMINES ROBUSTNESS OF THE DELAY OF CLOCK 
PHASE  
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Introduction 
 In chapter 3 of this dissertation, I present evidence that light exposure in the early night 
results in a rapid and transient depolymerization of actin state.  The changes measured in actin 
were seen with light pulses of 1-2 min, but by 4 min of light, no changes were seen in actin state.  
However, the changes seen in actin in mice receiving 1-2 min of light did not become 
significantly different until 12 experiments were completed.  This is due to a subset of 
experiments in which F/G-actin did not decrease upon light exposure.  The 1-2 min light pulse 
data presented in fig. 3.2 has been re-plotted in fig. A.1, showing the data from all 12 
experiments plotted individually.  These results led me to hypothesize that some mice lack a 
response to such short pulses of light.  These mice, termed “non-responders,” do not respond to 
short light pulses as robustly as they would to standard light pulses of 5 min or longer.  I have 
examined wheel-running behavior and induction of a marker of activation of the light signaling 
pathway, PERK, in mice receiving brief light pulses compared to longer exposure to light.  
Results show variable responses of behavioral changes to short light exposure, as well as little to 
no PERK induction with brief pulses of light. 
 
Materials and Methods 
Animals and circadian time 
 Male C57Bl/6 mice 6-12 weeks of age, obtained from Jackson Laboratories (Bar Harbor, 
ME) were used for this study.  These rodents were housed under standard conditions in 12-h 
light:12-h dark (L:D) cycles or constant darkness (D:D) and given food and water ad libitum.  
All animals were housed and cared for in full compliance with NIH guidelines for the humane 
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treatment and care of animals and animal protocols have been approved by IACUC at the 
University of Illinois.   
 Mice were individually housed in a cage containing a running wheel, with two cages 
residing in a circadian activity monitoring system (CAMS).  These are light-tight, ventilated, and 
the lighting is specifically controlled for each CAMS by computer.  After adjusting to the wheel, 
mice were placed into these CAMS in constant darkness (D:D).  Running wheel activity was 
measured by rotation of the wheel.  This rotation causes a magnet on the wheel to pass a 
hermetically-sealed switch, which completes a circuit.  Onset of activity, which typically is 
designated as CT 12, was used to evaluate changes in the clock state.  This information was sent 
to a computer containing LabView software.  The information was then plotted into an actogram 
using Clocklab Analysis running in Matlab (Actimetric Inc., Wilmette, IL).  The magnitude of 
phase shift was determined by measuring the distance between the computer-generated 
regression lines plotted against onset of activity before and after treatments.    
Tissue collection and preparation 
 Following light pulse, mice were transcardially perfused with 50 ml cold 0.9% saline, 
followed by 50 ml 4% paraformaldehyde.  Whole brains from perfused mice were post-fixed in 
4% paraformaldehyde overnight and then sliced into 40-µm sections using a vibratome.  These 
were collected into Watson’s cryoprotectant for storage at -20°C.   
Immunohistochemistry 
 Upon thorough rinsing to remove cryoprotectant, slices were quenched in 1% H2O2/0.3% 
Triton X-100-PBS for 30 min, blocked in 5% normal goat serum/0.3% Triton X-100-PBS for 1 
h, and then incubated in anti-phospho-p42/p44 (PERK) antibody (Cell Signaling Technology, 
Danvers, MA) in PBS containing 2% normal goat serum/0.3% Triton X-100 for 36-48 h at 4°C.  
 85 
 
Slices were then incubated in biotin-conjugated anti-rabbit antibody (1.5 µg/ml) for 1 h at room 
temperature before ABC conjugation and DAB staining according to directions provided by the 
manufacturer (Vectastain Elite ABC kit, Vector Labs, Burlingame, CA).  Staining was evaluated 
using a Nikon fluorescent microscope. 
 
Results 
Brief light pulses in early night produce variable delays in behavior 
 In order to examine whether light pulses of 1-2 min affect individual mice differently, 4 
mice received 7 light pulse treatments: 2 initial 1-min pulses, followed by 2, 4, 6, and 15 min of 
bright (>500 lux) light at ZT 14.  After treatment, mice were placed into constant dark conditions 
(D:D), and running wheel activity was monitored for 10 days between each light administration.  
Each mouse received all treatments, plus an additional 1-min light pulse as the final treatment to 
test whether mice respond more robustly after running for a longer duration.  The magnitude of 
their responses for each dose of light is presented in figure A.2.  Individual data is plotted, as 
well as the averaged results.  Of the 4 mice, 3 delayed in response to 1 min of light, though 
variably, but the fourth advanced.  A second 1-min pulse of light yielded delays of a different 
magnitude in 2 of the 4 mice.  Two min of light yielded the same result.  By 4 min, all 4 mice 
showed a delay in wheel-running onset that was approximately 0.5-hr or larger in magnitude.  
Examples of each response are shown in the actograms in figure A.3.  This small study indicates 
that individual mice respond to short light pulses variably, but all mice respond with a delay of 
equal magnitude to light pulses of 4-min or longer.  
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Brief light pulses in early night do not induce a robust induction of signaling components 
  A second experiment was undertaken to examine PERK induction with short light 
pulses.  Light pulses of 15-min in early night robustly increase phosphorylation of ERK in the 
SCN (Fig. A.5 A) 82.  Prior to histochemical examination of PERK, mice were evaluated for 
running-wheel behavior after 2 separate, 1-min light pulses to identify potential responders and 
non-responders.  The results of this and representative actograms are given in figure A.4.  Of the 
6 mice, 2 responded to one of the 1-min LPs with a large advance in running-wheel onset, and in 
all cases, there was variability between mice, and, unexpectedly, from treatment to treatment 
within the same mouse.   
 After completion of the behavioral assays, the same mice received a 1-min light pulse of 
bright (>500 lux) light at ZT 14, after which they were returned to dim red light.  As controls, 6 
mice were perfused in dim red light, shown to cause no changes in the clock (Arnold and 
Gillette, unpublished observations), and collected as for the light-pulsed mice.  Brain slices from 
these mice were probed for PERK to determine if the signaling pathway in the SCN was 
activated.  Results from 1 representative set of mice are shown in figure A.5 B.  For comparison, 
results from a mouse that received a 15-min light pulse are also shown.  Mice receiving 1 min of 
light show very little difference in PERK staining from the dark controls.  This second 
experiment demonstrates that brief light pulses, while causing behavioral delays in some mice, 
do not induce the signaling components as robustly as longer light pulses. 
 
Discussion 
 These two small studies demonstrate the variability in response of mice to very brief light 
pulses in early night.  For both sets of mice, 1-min light pulses induce a range of responses from 
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advances of >1 hr to delays of >1 hr.  As the length of light exposure increases, the number of 
mice responding with a delay of over 30 min increases, so that with 4 or more min of light, all 
mice are delaying.  When activation of a signaling element, PERK, was evaluated by 
immunohistochemistry, all 6 mice that were probed for PERK show low levels of PERK 
induction following a 1-min LP.  This suggests that the light signaling pathway in these mice is 
not activated in the majority of cells in the SCN, as PERK induction after 5 min or more of light 
exposure typically is robust and distributed through most of the middle of the SCN 82.   
 These studies were carried out after examining the individual replicates of a light pulse 
experiment measuring actin change.  The 12 repeats of this experiment resulted in the F/G-actin 
ratio ranging from 53% of control to 112% of control levels.  Even though tissue from 3 mice 
were pooled for each treatment in each replicate, if one or more of the mice is a non-responder, 
this could account for the variability in this experiment.  Unfortunately, because actin changes 
occur so quickly following activation of the signaling pathway, it is not possible to expose mice 
to longer durations of light in order to guarantee a response.  The study presented in this 
appendix, however, helps explain a possible source of the high variability in these experiments. 
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Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. A.1 Light induces a transient decrease in F-actin.  Light pulses of 1-2 min induce a 
decrease in the F-:G-actin ratio of 15 ± 6% relative to non-light pulsed controls.  Individual 
points are plotted over the average value for each time (solid line).  * p < 0.05, Student’s T-test, 
n = 12.  
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Fig. A.2 Varying lengths of light pulse affects magnitude of delay.  A. Mice #1-4 received 
bright (>500 lux) pulses of light of the given lengths, and then running-wheel onset was assessed 
for changes in clock state. B. Summary of responses for all mice.  All 1-min LPs were pooled 
from (A) for the result shown in (B).  LP = light pulse. 
Mouse
1 2 4 6 15
-1.5
-1.0
-0.5
0.0
min of LP
Ph
as
e 
C
ha
ng
e 
(h
rs
)
 90 
 
 
 
 
Fig. A.3 Varying lengths of light pulse affects magnitude of delay. Representative actograms 
from 1 mouse receiving 1-15 mins of bright light.  Yellow arrow indicates light pulse treatment 
time, and the resulting phase change (in hrs) is given above the actogram along with the 
treatment.  LP = light pulse. 
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Fig. A.4 Variable responses to short light pulses.  A. Each representative actogram shows the 
response of 1 mouse to a 1-min pulse of bright light at ZT 14.  The response is shown above each 
actogram in hrs. B. Summary of 6 mice for each 1-min light pulse (LP). 
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Fig. A.5 Induction of PERK by light depends on light pulse length.  A. Bright light exposure 
for 15 min at ZT 14 induces a robust increase in PERK staining compared to a non light-pulsed 
control.  B. Bright light exposure for 1 min at ZT 14 does not result in a robust increase in PERK 
induction.  1-min images are representative of 6 replicates.  Scale bar = 100 µm. 
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